,SYMBOL,COMPANY NAME,SUBJECT,DETAILS,BROADCAST DATE/TIME,RECEIPT,DISSEMINATION,DIFFERENCE,ATTACHMENT,Date,Open,High,Low,Close,Adj Close,Volume,Dividends,Stock Splits,Next_Date,Sentiment
0,DIVISLAB,Divi's Laboratories Limited,analysts/institutional investor meet/con. call updates," about transcript of q3fy24 earnings call held on february 10, 2024.",16-Feb-2024 17:04:36,2024-02-16 17:04:36,16-Feb-2024 17:04:42,00:00:06,https://nsearchives.nseindia.com/corporate/DIVISLAB_16022024170436_Q3FY24Earnings_Call_DivisLab.pdf,16-02-2024,3708.699951171875,3778.89990234375,3708.0,3729.199951171875,3729.199951171875,625808,0.0,0.0,23-02-2024,0
1,DIVISLAB,Divi's Laboratories Limited,board meeting intimation, about board meeting to be held on 10-feb-2024 to inter-alia consider and approve the unaudited financial results of the company for the quarterly ended december 2023 .,30-Jan-2024 14:45:52,2024-01-30 14:45:52,30-Jan-2024 14:45:58,00:00:06,https://nsearchives.nseindia.com/corporate/xbrl/DIVISLAB_30012024144552_PRIOR_INTIMATION_17583_1038759_30012024024551_WEB.xml,30-01-2024,3574.949951171875,3619.35009765625,3540.300048828125,3551.699951171875,3551.699951171875,1052177,0.0,0.0,06-02-2024,0
2,DIVISLAB,Divi's Laboratories Limited,updates," regarding 'disclosure under regulation 30 of the sebi (listing obligations and disclosure requirements), regulations, 2015 '.",16-Nov-2023 11:15:58,2023-11-16 11:15:58,16-Nov-2023 11:16:04,00:00:06,https://nsearchives.nseindia.com/corporate/DIVISLAB_16112023111558_Regulation30_intimation_16112023.pdf,16-11-2023,3536.85009765625,3570.39990234375,3520.0,3548.25,3548.25,249987,0.0,0.0,23-11-2023,0
3,DIVISLAB,Divi's Laboratories Limited,financial result updates,", the financial results for the period ended september 30, 2023.",06-Nov-2023 12:27:43,2023-11-06 12:27:43,06-Nov-2023 12:27:48,00:00:05,https://nsearchives.nseindia.com/corporate/OutcomeofBoardMeeting_Q2FY24Results_06112023122743.pdf,06-11-2023,3360.0,3530.89990234375,3295.300048828125,3506.699951171875,3506.699951171875,1821472,0.0,0.0,13-11-2023,0
4,DIVISLAB,Divi's Laboratories Limited,press release (revised)," regarding a revised press release dated september 26, 2023, titled ""press release - usfda delegation visits the company s unit i at choutuppal, telangana, india"".",26-Sep-2023 15:11:45,2023-09-26 15:11:45,26-Sep-2023 15:11:48,00:00:03,https://nsearchives.nseindia.com/corporate/DIVISLAB_26092023151145_Press_Release_26092023.pdf,26-09-2023,3719.949951171875,3764.39990234375,3707.0,3753.800048828125,3753.800048828125,251701,0.0,0.0,04-10-2023,0
5,DIVISLAB,Divi's Laboratories Limited,press release," regarding a press release dated september 26, 2023, titled ""press release - usfda delegation visits the company s unit i at choutuppal, telangana, india"".",26-Sep-2023 15:00:10,2023-09-26 15:00:10,26-Sep-2023 15:00:21,00:00:11,https://nsearchives.nseindia.com/corporate/DIVISLAB_26092023150011_Press_Release.pdf,26-09-2023,3719.949951171875,3764.39990234375,3707.0,3753.800048828125,3753.800048828125,251701,0.0,0.0,04-10-2023,0
6,DIVISLAB,Divi's Laboratories Limited,change in directors/ key managerial personnel/ auditor/ compliance officer/ share transfer agent, about change in directors/ key managerial personnel/ auditor/ compliance officer/ share transfer agent,28-Aug-2023 18:14:46,2023-08-28 18:14:46,28-Aug-2023 18:14:51,00:00:05,https://nsearchives.nseindia.com/corporate/xbrl/DIVISLAB_28082023181446_CIM_9985_923786_28082023061446_WEB.xml,28-08-2023,3630.0,3656.949951171875,3621.10009765625,3633.25,3633.25,196064,0.0,0.0,04-09-2023,0
7,DIVISLAB,Divi's Laboratories Limited,resignation," regarding resignation of mr madhusudana rao divi  as whole-time director of the company w.e.f. august 28, 2023.",28-Aug-2023 18:06:03,2023-08-28 18:06:03,28-Aug-2023 18:06:08,00:00:05,https://nsearchives.nseindia.com/corporate/DIVISLAB_28082023180603_Intimation_Reg30_DirectorRetirement.pdf,28-08-2023,3630.0,3656.949951171875,3621.10009765625,3633.25,3633.25,196064,0.0,0.0,04-09-2023,0
8,DIVISLAB,Divi's Laboratories Limited,shareholders meeting," regarding proceedings of annual general meeting held on august 28, 2023. further, the company has submitted the exchange a copy of srutinizers report along with voting results.",28-Aug-2023 17:02:55,2023-08-28 17:02:55,28-Aug-2023 17:02:59,00:00:04,https://nsearchives.nseindia.com/corporate/DIVISLAB_28082023170255_Outcome_33rdAGM_DIVISLAB.pdf,28-08-2023,3630.0,3656.949951171875,3621.10009765625,3633.25,3633.25,196064,0.0,0.0,04-09-2023,0
9,DIVISLAB,Divi's Laboratories Limited,updates," regarding 'compliance of regulation 30(5) of sebi (listing obligations and disclosure requirements) regulations, 2015'.",14-Aug-2023 16:31:26,2023-08-14 16:31:26,14-Aug-2023 16:31:37,00:00:11,https://nsearchives.nseindia.com/corporate/DIVISLAB_14082023163126_Intimation_regulation_30_5_.pdf,14-08-2023,3645.10009765625,3747.449951171875,3601.75,3730.550048828125,3730.550048828125,1295993,0.0,0.0,22-08-2023,0
10,DIVISLAB,Divi's Laboratories Limited,financial result updates,", the financial results for the period ended june 30, 2023.",14-Aug-2023 12:55:25,2023-08-14 12:55:25,14-Aug-2023 12:55:35,00:00:10,https://nsearchives.nseindia.com/corporate/Outcome_BoardMeeting_Q1FY24results_14082023125525.pdf,14-08-2023,3645.10009765625,3747.449951171875,3601.75,3730.550048828125,3730.550048828125,1295993,0.0,0.0,22-08-2023,0
11,DIVISLAB,Divi's Laboratories Limited,board meeting intimation, about board meeting to be held on 14-aug-2023 to inter-alia consider and approve the unaudited financial results of the company for the quarterly ended june 2023 .,07-Aug-2023 11:11:33,2023-08-07 11:11:33,07-Aug-2023 11:11:45,00:00:12,https://nsearchives.nseindia.com/corporate/xbrl/DIVISLAB_07082023111133_PRIOR_INTIMATION_9014_909713_07082023111133_WEB.xml,07-08-2023,3762.89990234375,3920.0,3760.0,3910.550048828125,3879.22802734375,1124433,0.0,0.0,14-08-2023,0
12,DIVISLAB,Divi's Laboratories Limited,notice of shareholders meetings-xbrl, about notice of shareholders meeting for annual general meeting to be held on 28-aug-2023,07-Aug-2023 10:47:21,2023-08-07 10:47:21,07-Aug-2023 10:47:31,00:00:10,https://nsearchives.nseindia.com/corporate/xbrl/DIVISLAB_07082023104721_NOTICE_OF_SHAREHOLDERS_MEETINGS_909702_07082023104721_WEB.xml,07-08-2023,3762.89990234375,3920.0,3760.0,3910.550048828125,3879.22802734375,1124433,0.0,0.0,14-08-2023,0
13,DIVISLAB,Divi's Laboratories Limited,updates," regarding 'business responsibility and sustainability report for the financial year ended march 31, 2023'.",03-Aug-2023 10:04:30,2023-08-03 10:04:30,03-Aug-2023 10:04:43,00:00:13,https://nsearchives.nseindia.com/corporate/DIVISLAB_03082023100430_Submission_BRSR2022_23_Divis.pdf,03-08-2023,3700.0,3764.800048828125,3690.199951171875,3726.300048828125,3696.453857421875,619764,0.0,0.0,10-08-2023,0
14,DIVISLAB,Divi's Laboratories Limited,shareholders meeting," regarding notice of annual general meeting to be held on august 28, 2023",02-Aug-2023 17:08:15,2023-08-02 17:08:15,02-Aug-2023 17:08:28,00:00:13,https://nsearchives.nseindia.com/corporate/DIVISLAB_02082023170815_Submission_Annual_Report2022_23_Divis.pdf,02-08-2023,3630.0,3695.0,3577.050048828125,3690.60009765625,3661.039794921875,681092,0.0,0.0,09-08-2023,0
15,DIVISLAB,Divi's Laboratories Limited,copy of newspaper publication," about copy of newspaper publication - notice informing 33rd annual general meeting of the company to be held on august 28, 2023 through video conferencing (vc) / other audio-visual means (oavm), record date for dividend and other information",28-Jul-2023 12:59:49,2023-07-28 12:59:49,28-Jul-2023 12:59:56,00:00:07,https://nsearchives.nseindia.com/corporate/DIVISLAB_28072023125949_Intimation_Newspaperclipping_AGM.pdf,28-07-2023,3769.0,3775.0,3710.0,3739.050048828125,3709.101806640625,355259,0.0,0.0,04-08-2023,0
16,DIVISLAB,Divi's Laboratories Limited,updates, regarding 'communication to shareholders - information regarding deduction of income tax at source from payment of dividend for the financial year 2022-23'.,05-Jul-2023 09:02:05,2023-07-05 09:02:05,05-Jul-2023 09:02:12,00:00:07,https://nsearchives.nseindia.com/corporate/DIVISLAB_05072023090205_Submission_DividendTDS_communcation.pdf,05-07-2023,3576.39990234375,3775.0,3563.14990234375,3747.949951171875,3717.930419921875,1611582,0.0,0.0,12-07-2023,0
17,DIVISLAB,Divi's Laboratories Limited,updates, regarding 'intimation of date of 33rd annual general meeting and record date for dividend'.,03-Jul-2023 12:44:26,2023-07-03 12:44:26,03-Jul-2023 12:44:33,00:00:07,https://nsearchives.nseindia.com/corporate/DIVISLAB_03072023124426_Intimation_of_33rdAGM_date_and_Record_date.pdf,03-07-2023,3586.800048828125,3652.0,3576.25,3587.550048828125,3558.815185546875,574958,0.0,0.0,10-07-2023,0
18,DIVISLAB,Divi's Laboratories Limited,trading window," regarding the trading window closure pursuant to sebi (prohibition of insider trading) regulations, 2015",28-Jun-2023 16:08:24,2023-06-28 16:08:24,28-Jun-2023 16:08:28,00:00:04,https://nsearchives.nseindia.com/corporate/DIVISLAB_28062023160824_Intimation_TradingWindowClosure_Q1Fy24.pdf,28-06-2023,3585.050048828125,3631.699951171875,3585.050048828125,3601.550048828125,3572.703125,454010,0.0,0.0,06-07-2023,0
19,DIVISLAB,Divi's Laboratories Limited,annual secretarial compliance report,"annual secretarial compliance report for the year ended march 31, 2023",23-May-2023 10:07:37,2023-05-23 10:07:37,23-May-2023 10:07:42,00:00:05,https://nsearchives.nseindia.com/corporate/DIVISLAB_23052023100737_Reg24A_AnnualSecretarialCompliancecertificate31032023.pdf,23-05-2023,3241.050048828125,3415.0,3221.050048828125,3385.800048828125,3358.68115234375,1376245,0.0,0.0,30-05-2023,0
20,DIVISLAB,Divi's Laboratories Limited,disclosure under sebi takeover regulations,"dr. murali k. divi has submitted to the exchange a copy of disclosure under regulation 31(4) of the securities and exchange board of india (substantial acquisition of shares and takeovers) regulations, 2011.",19-May-2023 16:33:59,2023-05-19 16:33:59,19-May-2023 16:34:05,00:00:06,https://nsearchives.nseindia.com/corporate/DIVISLAB_19052023163359_Reg.pdf,19-05-2023,3144.0,3158.35009765625,3085.5,3098.300048828125,3073.48388671875,479974,0.0,0.0,26-05-2023,1
21,DIVISLAB,Divi's Laboratories Limited,board meeting intimation, about board meeting to be held on 20-may-2023 to consider and approve the yearly audited financial results of the company for the period ended march 2023 and dividend.,12-May-2023 10:47:08,2023-05-12 10:47:08,12-May-2023 10:47:10,00:00:02,https://nsearchives.nseindia.com/corporate/xbrl/DIVISLAB_12052023104708_PRIOR_INTIMATION_4149_841090_12052023104707_WEB.xml,12-05-2023,3311.0,3354.0,3190.0,3315.050048828125,3288.497802734375,957967,0.0,0.0,19-05-2023,-1
22,DIVISLAB,Divi's Laboratories Limited,trading window," regarding the trading window closure pursuant to sebi (prohibition of insider trading) regulations, 2015",31-Mar-2023 10:16:57,2023-03-31 10:16:57,31-Mar-2023 10:17:02,00:00:05,https://nsearchives.nseindia.com/corporate/DIVISLAB_31032023101657_Intimation_trading_window_closure_31032023.pdf,31-03-2023,2834.39990234375,2840.25,2810.800048828125,2823.35009765625,2800.736083984375,362732,0.0,0.0,11-04-2023,0
23,DIVISLAB,Divi's Laboratories Limited,financial result updates,", the financial results for the period ended december 31, 2022.",03-Feb-2023 12:50:51,2023-02-03 12:50:51,03-Feb-2023 12:50:55,00:00:04,https://nsearchives.nseindia.com/corporate/Outcome_Q3FY23BoardMeeting_03022023_03022023125051.pdf,03-02-2023,3270.0,3270.0,2795.0,2884.35009765625,2861.24755859375,4486682,0.0,0.0,10-02-2023,0
24,DIVISLAB,Divi's Laboratories Limited,reply to clarification sought- financial results,"dear sir/madam,as soon as we have uploaded quick results on 12.08.2022, we realized the file was not readable and spoke to nse officials. we were advised to file the machine readable document of the submission under miscelleneous filings. we have filed machine readable outcome of board meeting vide application no. 2022082098491 on 12-aug-2022 at 13:03:43 hrs. we have seen the clarification raised just now and were unaware of the clarification requested till today. ",07-Nov-2022 17:34:09,2022-11-07 17:34:09,07-Nov-2022 17:34:13,00:00:04,https://nsearchives.nseindia.com/corporate/DIVISLAB_07112022173409_Acknowledgement_file_12Aug2022.pdf,07-11-2022,3749.0,3771.699951171875,3405.0,3414.550048828125,3387.200927734375,2860839,0.0,0.0,15-11-2022,0
25,DIVISLAB,Divi's Laboratories Limited,outcome of board meeting,divi's laboratories limited  has informed the exchange about board meeting held on 07-nov-2022 to consider financial statements for the period ended september 2022,07-Nov-2022 12:52:21,2022-11-07 12:52:21,07-Nov-2022 12:52:32,00:00:11,https://nsearchives.nseindia.com/corporate/DIVISLAB_07112022125221_Outcome_Board_MeetingQ2Fy23_DivisLab07112022.pdf,07-11-2022,3749.0,3771.699951171875,3405.0,3414.550048828125,3387.200927734375,2860839,0.0,0.0,15-11-2022,0
26,DIVISLAB,Divi's Laboratories Limited,general updates," about submission of certificate under regulation 74(5) of sebi (depositories and participants) regulations, 2018 for the quarter ended september 30, 2022",12-Oct-2022 10:43:09,2022-10-12 10:43:09,12-Oct-2022 10:43:16,00:00:07,https://nsearchives.nseindia.com/corporate/DIVISLAB_12102022104309_Certificate_74_5_DivisLabs30092022.pdf,12-10-2022,3510.0,3540.199951171875,3472.0,3527.800048828125,3499.543701171875,445779,0.0,0.0,19-10-2022,0
27,DIVISLAB,Divi's Laboratories Limited,annual general meeting," about voting results,  scrutinizer report and  proceedings of annual general meeting held on 22-aug-2022",22-Aug-2022 16:49:20,2022-08-22 16:49:20,22-Aug-2022 16:49:24,00:00:04,https://nsearchives.nseindia.com/corporate/DIVISLAB_22082022164920_Outcome_of_AGM_Proceedings_VotingResults_ScrutinizersReport_DivisLab22082022.pdf,22-08-2022,3653.0,3673.5,3558.050048828125,3580.64990234375,3551.97021484375,1050176,0.0,0.0,29-08-2022,0
28,DIVISLAB,Divi's Laboratories Limited,outcome of board meeting,divi's laboratories limited  has informed the exchange about board meeting held on 12-aug-2022 to consider financial statements for the period ended june 2022,12-Aug-2022 12:25:51,2022-08-12 12:25:51,12-Aug-2022 12:25:54,00:00:03,https://nsearchives.nseindia.com/corporate/DIVISLAB_12082022122551_Outcome_BoardMeeting_Q1FY23_12082022.pdf,12-08-2022,3950.050048828125,3958.199951171875,3700.0,3726.199951171875,3696.3544921875,2107936,0.0,0.0,22-08-2022,0
29,DIVISLAB,Divi's Laboratories Limited,newspaper advertisements," about newspaper advertisement regarding notice of the 32nd annual general meeting, e-voting and other information to the shareholders.",26-Jul-2022 12:02:18,2022-07-26 12:02:18,26-Jul-2022 12:02:22,00:00:04,https://nsearchives.nseindia.com/corporate/DIVISLAB_26072022120218_Newspaper_Publication_AGMnoticeDispatch_Evoting_DivisLab.pdf,26-07-2022,3774.300048828125,3793.85009765625,3680.25,3687.0,3629.681640625,247798,0.0,0.0,02-08-2022,0
30,DIVISLAB,Divi's Laboratories Limited,annual general meeting, about notice of annual general meeting to be held on 22-aug-2022,25-Jul-2022 10:47:24,2022-07-25 10:47:24,25-Jul-2022 10:47:27,00:00:03,https://nsearchives.nseindia.com/corporate/DIVISLAB_25072022104724_AnnualReport_AGMnotice_2021_22DivisLab.pdf,25-07-2022,3796.75,3818.0,3762.0,3774.300048828125,3715.624755859375,111963,0.0,0.0,01-08-2022,0
31,DIVISLAB,Divi's Laboratories Limited,newspaper advertisements," about newspaper advertisements - notice informing 32nd annual general meeting of the company to be held on august 22, 2022 through video conferencing (vc) / other audio-visual means (oavm).",20-Jul-2022 12:14:30,2022-07-20 12:14:30,20-Jul-2022 12:14:32,00:00:02,https://nsearchives.nseindia.com/corporate/DIVISLAB_20072022121430_Newspaper_Publication_Intimation_32ndAGM_through_VC_DivisLab.pdf,20-07-2022,3790.0,3790.0,3736.85009765625,3741.64990234375,3683.48193359375,223231,0.0,0.0,27-07-2022,0
32,DIVISLAB,Divi's Laboratories Limited,general updates," about certificate under regulation 74(5) of sebi (depositories and participants) regulations, 2018 for the quarter ended june 30, 2022",11-Jul-2022 12:56:00,2022-07-11 12:56:00,11-Jul-2022 12:56:11,00:00:11,https://nsearchives.nseindia.com/corporate/DIVISLAB_11072022125600_Certificate_reg745_30062022_Divislab.pdf,11-07-2022,3671.300048828125,3747.0,3633.699951171875,3734.10009765625,3676.049560546875,391665,0.0,0.0,18-07-2022,0
33,DIVISLAB,Divi's Laboratories Limited,general updates, about communication to shareholders - information regarding deduction of income tax at source on dividend,05-Jul-2022 14:38:57,2022-07-05 14:38:57,05-Jul-2022 14:39:00,00:00:03,https://nsearchives.nseindia.com/corporate/DIVISLAB_05072022143857_Intimation_TDScommunication_Divislab.pdf,05-07-2022,3670.0,3678.5,3605.25,3610.050048828125,3553.92822265625,342952,0.0,0.0,12-07-2022,0
34,DIVISLAB,Divi's Laboratories Limited,general updates, about intimation of date of annual general meeting and record date,04-Jul-2022 16:25:03,2022-07-04 16:25:03,04-Jul-2022 16:25:06,00:00:03,https://nsearchives.nseindia.com/corporate/DIVISLAB_04072022162503_Intimation_AGMdate_RecordDate_DivisLab.pdf,04-07-2022,3659.89990234375,3679.449951171875,3595.14990234375,3639.550048828125,3582.969482421875,199015,0.0,0.0,11-07-2022,0
35,DIVISLAB,Divi's Laboratories Limited,newspaper advertisements, about newspaper advertisements - intimation of notice given to shareholders in respect of transfer of equity shares to iepf account ,31-May-2022 14:49:42,2022-05-31 14:49:42,31-May-2022 14:49:52,00:00:10,https://nsearchives.nseindia.com/corporate/DIVISLAB_31052022144942_IEPFNotice_to_Shareholders_31052022.pdf,31-05-2022,3585.0,3627.949951171875,3530.0,3591.300048828125,3535.4697265625,1013666,0.0,0.0,07-06-2022,0
36,DIVISLAB,Divi's Laboratories Limited,outcome of board meeting,divi's laboratories limited  has informed the exchange about board meeting held on 23-may-2022 to consider financial statements for the period ended march 2022 and dividend,23-May-2022 12:29:41,2022-05-23 12:29:41,23-May-2022 12:29:49,00:00:08,https://nsearchives.nseindia.com/corporate/DIVISLAB_23052022122940_Outcome_Q4FY22_Divis.pdf,23-05-2022,4323.0,4438.7998046875,3874.35009765625,3897.89990234375,3837.302978515625,2180936,0.0,0.0,30-05-2022,-1
37,DIVISLAB,Divi's Laboratories Limited,dividend," that board of directors at its meeting held on 23-may-2022, declared dividend of rs. 30 per equity share.",23-May-2022 12:29:38,2022-05-23 12:29:38,23-May-2022 12:29:47,00:00:09,https://nsearchives.nseindia.com/corporate/DIVISLAB_23052022122931_Outcome_Q4FY22_Divis.pdf,23-05-2022,4323.0,4438.7998046875,3874.35009765625,3897.89990234375,3837.302978515625,2180936,0.0,0.0,30-05-2022,-1
38,DIVISLAB,Divi's Laboratories Limited,financial result updates,", the financial results for the period ended march 31, 2022.",23-May-2022 12:21:33,2022-05-23 12:21:33,23-May-2022 12:23:02,00:01:29,https://nsearchives.nseindia.com/corporate/Outcome_Q4FY22_Divis_23052022122133.pdf,23-05-2022,4323.0,4438.7998046875,3874.35009765625,3897.89990234375,3837.302978515625,2180936,0.0,0.0,30-05-2022,-1
39,DIVISLAB,Divi's Laboratories Limited,schedule of analysts/institutional investor meet/con. call, about schedule of analysts/institutional investor meet/con. call -  schedule of earnings conference call q4 and full year fy22 ,16-May-2022 16:43:10,2022-05-16 16:43:10,16-May-2022 16:43:17,00:00:07,https://nsearchives.nseindia.com/corporate/DIVISLAB_16052022164310_Schedule_of_Earnings_call_Q4FY22.pdf,16-05-2022,4291.0,4309.75,4210.0,4218.10009765625,4152.525390625,116360,0.0,0.0,23-05-2022,-1
40,DIVISLAB,Divi's Laboratories Limited,general updates," about submission of certificate under regulation 74(5) of sebi (depositories and participants) regulations, 2018 for the quarter ended march 31, 2022",08-Apr-2022 16:02:53,2022-04-08 16:02:53,08-Apr-2022 16:03:25,00:00:32,https://nsearchives.nseindia.com/corporate/DIVISLAB_08042022160253_Reg74_5_DivisLab31032022.pdf,08-04-2022,4449.89990234375,4528.10009765625,4412.0,4505.9501953125,4435.90087890625,241609,0.0,0.0,19-04-2022,0
41,DIVISLAB,Divi's Laboratories Limited,disclosure under sebi takeover regulations,promoter/promoter group of divi's laboratories limited has submitted a disclosure under regulation 31(4) of sebi takeover regulations for the year ended 31-mar-2022,04-Apr-2022 12:24:19,2022-04-04 12:24:19,04-Apr-2022 12:24:24,00:00:05,https://nsearchives.nseindia.com/corporate/AN_O04042022122419.xlsx,04-04-2022,4379.7001953125,4505.0,4378.89990234375,4497.60009765625,4427.68017578125,334083,0.0,0.0,11-04-2022,0
42,DIVISLAB,Divi's Laboratories Limited,closure of trading window," about closure of trading window that pursuant to the company's code of conduct for prevention of lnsider trading (the code),  trading window for dealing in securities of the company will remain closed for all designated persons and their immediate relatives, as well as insiders covered under the code, from april 01, 2022 till 48 hours after the declaration of audited financial results for the fourth quarter and year ending march 31, 2022.the date of board meeting for declaration of the financial results of the company for the fourth quarter and year ending march 31, 2022 will be intimated in due course.",31-Mar-2022 12:04:19,2022-03-31 12:04:19,31-Mar-2022 12:04:31,00:00:12,https://nsearchives.nseindia.com/corporate/DIVISLAB_31032022120419_Trading_Window_Closure_01042022.pdf,31-03-2022,4530.0,4553.5498046875,4390.64990234375,4402.0498046875,4333.615234375,611205,0.0,0.0,07-04-2022,0
43,DIVISLAB,Divi's Laboratories Limited,postal ballot," about voting results and  scrutinizer report of postal ballot, conducted vide notice of postal ballot dated february 11, 2022.",28-Mar-2022 14:14:57,2022-03-28 14:14:57,28-Mar-2022 14:15:01,00:00:04,https://nsearchives.nseindia.com/corporate/DIVISLAB_28032022141454_Voting_results_PostalBallot_DivisLab.pdf,28-03-2022,4433.0,4458.9501953125,4374.5,4416.5498046875,4347.8896484375,316896,0.0,0.0,04-04-2022,0
44,DIVISLAB,Divi's Laboratories Limited,general updates, about change of name of the registrar and share transfer agent of the company from ￢ﾀﾜkfin technologies private limited￢ﾀﾝ to ￢ﾀﾜkfin technologies limited￢ﾀﾝ,22-Mar-2022 15:09:16,2022-03-22 15:09:16,22-Mar-2022 15:09:23,00:00:07,https://nsearchives.nseindia.com/corporate/DIVISLAB_22032022150914_Intimation_RTAnamechange_22032022_DivisLab.pdf,22-03-2022,4456.25,4493.75,4410.0,4448.5498046875,4379.392578125,292831,0.0,0.0,29-03-2022,0
45,DIVISLAB,Divi's Laboratories Limited,financial result updates,", the financial results for the period ended december 31, 2021.",11-Feb-2022 11:59:27,2022-02-11 11:59:27,11-Feb-2022 12:01:01,00:01:34,https://nsearchives.nseindia.com/corporate/ResultsQ3FY22_DivisLabs_11022022115927.pdf,11-02-2022,4313.75,4474.0,4240.0498046875,4291.25,4224.5380859375,2585446,0.0,0.0,18-02-2022,0
46,DIVISLAB,Divi's Laboratories Limited,trading window," regarding the trading window closure pursuant to sebi (prohibition of insider trading) regulations, 2015",31-Dec-2021 10:21:22,2021-12-31 10:21:22,31-Dec-2021 10:21:31,00:00:09,https://nsearchives.nseindia.com/corporate/DIVISLAB_31122021102122_Intimation_TradingWindowClosure_31122021.pdf,31-12-2021,4649.0,4690.0,4630.0,4678.2001953125,4605.47265625,293933,0.0,0.0,07-01-2022,0
47,DIVISLAB,Divi's Laboratories Limited,trading window," regarding the trading window closure pursuant to sebi (prohibition of insider trading) regulations, 2015",30-Sep-2021 10:24:37,2021-09-30 10:24:37,30-Sep-2021 10:24:45,00:00:08,https://nsearchives.nseindia.com/corporate/DIVISLAB_30092021102437_Intimation_TradingWindowClosure_Q2DivisLabs.pdf,30-09-2021,4797.0,4844.85009765625,4765.60009765625,4798.7001953125,4724.099609375,541396,0.0,0.0,07-10-2021,1
48,DIVISLAB,Divi's Laboratories Limited,shareholders meeting," regarding proceedings of annual general meeting held on august 30, 2021. further, the company has submitted the exchange a copy of srutinizers report along with voting results.",30-Aug-2021 17:12:03,2021-08-30 17:12:03,30-Aug-2021 17:12:10,00:00:07,https://nsearchives.nseindia.com/corporate/DIVISLAB_30082021171203_AGMproceedings_VotingResults_ScrutinizersReport_DivisLabs30082021.pdf,30-08-2021,4932.60009765625,5133.9501953125,4930.0,5104.25,5024.89892578125,866739,0.0,0.0,06-09-2021,0
49,DIVISLAB,Divi's Laboratories Limited,updates, regarding 'chairman s speech and managing director s speech delivered at the 31st annual general meeting of the company'.,30-Aug-2021 12:15:06,2021-08-30 12:15:06,30-Aug-2021 12:15:12,00:00:06,https://nsearchives.nseindia.com/corporate/DIVISLAB_30082021121506_AGMSpeeches2021DivisLab.pdf,30-08-2021,4932.60009765625,5133.9501953125,4930.0,5104.25,5024.89892578125,866739,0.0,0.0,06-09-2021,0
50,DIVISLAB,Divi's Laboratories Limited,shareholders meeting," regarding notice of annual general meeting to be held on august 30, 2021",02-Aug-2021 13:19:49,2021-08-02 13:19:49,02-Aug-2021 13:19:53,00:00:04,https://nsearchives.nseindia.com/corporate/DIVISLAB_02082021131949_Annual_Report_2020_21_DivisLabs.pdf,02-08-2021,4893.5,4962.14990234375,4893.5,4928.9501953125,4832.51513671875,359231,0.0,0.0,09-08-2021,0
51,DIVISLAB,Divi's Laboratories Limited,book closure, that register of members & share transfer books of the company will remain closed from 20-aug-2021 to 22-aug-2021 for the purpose of dividend.,19-Jul-2021 16:38:42,2021-07-19 16:38:42,19-Jul-2021 16:38:45,00:00:03,https://nsearchives.nseindia.com/corporate/DIVISLAB_19072021163842_Intimation_AGMdateBookClosure_19072021.pdf,19-07-2021,4749.9501953125,4832.7001953125,4735.5498046875,4807.4501953125,4713.39208984375,493155,0.0,0.0,27-07-2021,0
52,DIVISLAB,Divi's Laboratories Limited,updates, regarding 'intimation of date of annual general meeting and book closure'.,19-Jul-2021 16:32:59,2021-07-19 16:32:59,19-Jul-2021 16:33:03,00:00:04,https://nsearchives.nseindia.com/corporate/DIVISLAB_19072021163259_Intimation_AGMdateBookClosure_19072021.pdf,19-07-2021,4749.9501953125,4832.7001953125,4735.5498046875,4807.4501953125,4713.39208984375,493155,0.0,0.0,27-07-2021,0
53,DIVISLAB,Divi's Laboratories Limited,trading window," regarding the trading window closure pursuant to sebi (prohibition of insider trading) regulations, 2015",30-Jun-2021 10:16:30,2021-06-30 10:16:30,30-Jun-2021 10:16:40,00:00:10,https://nsearchives.nseindia.com/corporate/DIVISLAB_30062021101630_Intimation_TradingWindowClosure_DivisLab30062021.pdf,30-06-2021,4369.0,4432.0,4355.0498046875,4408.25,4322.00244140625,636015,0.0,0.0,07-07-2021,0
54,DIVISLAB,Divi's Laboratories Limited,disclosure under sebi takeover regulations,"ￂﾠpromoter/member of the promoter group of the company has informed the exchange regarding disclosure under regulation 30 of sebi sast regulations, 2011 as on march 31, 2021.",10-May-2021 18:37:29,2021-05-10 18:37:29,10-May-2021 18:37:39,00:00:10,https://nsearchives.nseindia.com/corporate/DIVISLAB_10052021183729_divis.pdf,10-05-2021,4052.0,4205.0,4042.10009765625,4139.2998046875,4058.31396484375,1238763,0.0,0.0,18-05-2021,0
55,DIVISLAB,Divi's Laboratories Limited,disclosure under sebi takeover regulations,"ￂﾠpromoter/member of the promoter group of the company has informed the exchange regarding disclosure under regulation 30 and regulation 31(4) of sebi sast regulations 2011ￂﾠas at march 31, 2021.",22-Apr-2021 11:03:14,2021-04-22 11:03:14,22-Apr-2021 11:03:21,00:00:07,https://nsearchives.nseindia.com/corporate/DIVISLAB_22042021110313_Divi30_22042021095724.zip,22-04-2021,3770.0,3812.050048828125,3742.199951171875,3755.25,3681.7783203125,619485,0.0,0.0,29-04-2021,0
56,DIVISLAB,Divi's Laboratories Limited,disclosure under sebi takeover regulations,"promoter/member of the promoter group of the company has informed the exchange regarding disclosure under regulation 30 and regulation 31(4) of sebi sast regulations 2011 as on march 31, 2021",15-Apr-2021 15:19:30,2021-04-15 15:19:30,15-Apr-2021 15:19:34,00:00:04,https://nsearchives.nseindia.com/corporate/DIVISLAB_15042021151929_divi_15042021142850.zip,15-04-2021,3745.5,3819.89990234375,3695.550048828125,3783.39990234375,3709.377685546875,850076,0.0,0.0,23-04-2021,0
57,DIVISLAB,Divi's Laboratories Limited,trading window," regarding the trading window closure pursuant to sebi (prohibition of insider trading) regulations, 2015",31-Mar-2021 08:39:40,2021-03-31 08:39:40,31-Mar-2021 08:39:50,00:00:10,https://nsearchives.nseindia.com/corporate/DIVISLAB_31032021083940_Intimation_TradingWindowClosure_31032021_Divislab.pdf,31-03-2021,3600.0,3640.64990234375,3581.0,3622.800048828125,3551.919677734375,883699,0.0,0.0,08-04-2021,0
58,DIVISLAB,Divi's Laboratories Limited,trading window," regarding the trading window closure pursuant to sebi (prohibition of insider trading) regulations, 2015",31-Dec-2020 11:31:23,2020-12-31 11:31:23,31-Dec-2020 11:31:28,00:00:05,https://nsearchives.nseindia.com/corporate/DIVISLAB_31122020113123_Intimation_TradingWIndowClosure_31122020_DivisLab.pdf,31-12-2020,3787.0,3850.0,3786.85009765625,3841.89990234375,3766.73291015625,646191,0.0,0.0,07-01-2021,0
59,DIVISLAB,Divi's Laboratories Limited,updates, regarding 'commencement of construction of divi's laboratories unit-iii facility near kakinada'.,01-Dec-2020 10:52:26,2020-12-01 10:52:26,01-Dec-2020 10:52:29,00:00:03,https://nsearchives.nseindia.com/corporate/DIVISLAB_01122020105226_Intimation_Unit3_DivisLab01122020.pdf,01-12-2020,3770.0,3770.0,3596.60009765625,3620.75,3549.90966796875,2077864,0.0,0.0,08-12-2020,0
60,DIVISLAB,Divi's Laboratories Limited,updates," regarding 'revised  disclosure under regulation 7(2) of sebi (prohibition ofinsider trading) regulations, 2015'.",23-Nov-2020 16:43:56,2020-11-23 16:43:56,23-Nov-2020 16:44:00,00:00:04,https://nsearchives.nseindia.com/corporate/DIVISLAB_23112020164356_Revised_PIT_Disclosure.pdf,23-11-2020,3486.39990234375,3637.800048828125,3470.5,3546.300048828125,3476.91650390625,2306539,0.0,0.0,01-12-2020,0
61,DIVISLAB,Divi's Laboratories Limited,updates," regarding 'intimation under regulation 30 of the sebi (listing obligations and disclosure requirements) regulations, 2015'.",23-Oct-2020 14:06:37,2020-10-23 14:06:37,23-Oct-2020 14:06:41,00:00:04,https://nsearchives.nseindia.com/corporate/DIVISLAB_23102020140637_Reg30_Intimation_DivisLab_23102020.pdf,23-10-2020,3109.0,3144.0,3062.64990234375,3068.85009765625,3008.807861328125,1214597,0.0,0.0,30-10-2020,0
62,DIVISLAB,Divi's Laboratories Limited,updates," regarding 'submission of certificate under regulation 74(5) of sebi (depositories andparticipants) regulations, 2018 for the quarter ended 30 september, 2020'.",13-Oct-2020 10:54:20,2020-10-13 10:54:20,13-Oct-2020 10:54:24,00:00:04,https://nsearchives.nseindia.com/corporate/DIVISLAB_13102020105420_Reg74_5_30092020_DivisLab.pdf,13-10-2020,3214.0,3248.0,3121.10009765625,3139.14990234375,3077.732177734375,1080242,0.0,0.0,20-10-2020,0
63,DIVISLAB,Divi's Laboratories Limited,trading window," regarding the trading window closure pursuant to sebi (prohibition of insider trading) regulations, 2015",30-Sep-2020 09:54:32,2020-09-30 09:54:32,30-Sep-2020 09:54:36,00:00:04,https://nsearchives.nseindia.com/corporate/DIVISLAB_30092020095432_Intimation_TradingWindowClosure_DivisLabs30092020.pdf,30-09-2020,3089.0,3135.0,3040.0,3047.949951171875,2988.316650390625,1416088,0.0,0.0,08-10-2020,1
64,DIVISLAB,Divi's Laboratories Limited,shareholders meeting," regarding proceedings of annual general meeting held on september 14, 2020. further, the company has submitted the exchange a copy of srutinizers report along with voting results.",14-Sep-2020 18:55:48,2020-09-14 18:55:48,14-Sep-2020 18:55:52,00:00:04,https://nsearchives.nseindia.com/corporate/DIVISLAB_14092020185548_AGMproceedings_Voting_ScrutinizersReport_DivisLabs14092020.pdf,14-09-2020,3169.60009765625,3227.64990234375,3133.699951171875,3164.800048828125,3102.88037109375,773804,0.0,0.0,21-09-2020,0
65,DIVISLAB,Divi's Laboratories Limited,updates, regarding 'chairman s speech and managing director s speech delivered at the 30th annual general meeting of the company'.,14-Sep-2020 12:30:41,2020-09-14 12:30:41,14-Sep-2020 12:30:48,00:00:07,https://nsearchives.nseindia.com/corporate/DIVISLAB_14092020123041_Chairman_MD_Speech_DivisAGM_14092020.pdf,14-09-2020,3169.60009765625,3227.64990234375,3133.699951171875,3164.800048828125,3102.88037109375,773804,0.0,0.0,21-09-2020,0
66,DIVISLAB,Divi's Laboratories Limited,shareholders meeting," regarding notice of annual general meeting to be held on september 14, 2020",19-Aug-2020 10:57:48,2020-08-19 10:57:48,19-Aug-2020 10:57:54,00:00:06,https://nsearchives.nseindia.com/corporate/DIVISLAB_19082020105748_30th_AnnualReport_201920_DivisLabs.pdf,19-08-2020,3166.64990234375,3190.0,3140.449951171875,3159.60009765625,3097.782470703125,1002926,0.0,0.0,26-08-2020,0
67,DIVISLAB,Divi's Laboratories Limited,book closure, that register of members & share transfer books of the company will remain closed from 08-sep-2020 to 14-sep-2020 for the purpose of annual general meeting.,17-Aug-2020 18:02:18,2020-08-17 18:02:18,17-Aug-2020 18:02:22,00:00:04,https://nsearchives.nseindia.com/corporate/DIVISLAB_17082020180218_Intimation_AGMdate_DivisLab.pdf,17-08-2020,3120.0,3139.0,3071.35009765625,3129.550048828125,3068.320068359375,1194516,0.0,0.0,24-08-2020,0
68,DIVISLAB,Divi's Laboratories Limited,updates," regarding '30th annual general meeting of the company to be held on 14 september, 2020 '.",17-Aug-2020 17:56:15,2020-08-17 17:56:15,17-Aug-2020 17:56:20,00:00:05,https://nsearchives.nseindia.com/corporate/DIVISLAB_17082020175615_Intimation_AGMdate_DivisLab.pdf,17-08-2020,3120.0,3139.0,3071.35009765625,3129.550048828125,3068.320068359375,1194516,0.0,0.0,24-08-2020,0
69,DIVISLAB,Divi's Laboratories Limited,analysts/institutional investor meet/con. call updates," about analysts/institutional investor meet/con. call updates - schedule of earnings conference call q1 fy21 to be held on 08 august, 2020",05-Aug-2020 15:21:42,2020-08-05 15:21:42,05-Aug-2020 15:22:13,00:00:31,https://nsearchives.nseindia.com/corporate/DIVISLAB_05082020152142_SE_Intimation_earnings_callQ1_Divis.pdf,05-08-2020,2700.0,2716.60009765625,2641.0,2667.75,2615.555419921875,1237767,0.0,0.0,12-08-2020,1
70,DIVISLAB,Divi's Laboratories Limited,updates," regarding 'submission of certificate under regulation 74(5) of sebi (depositories andparticipants) regulations, 2018 for the quarter ended 30 june, 2020'.",15-Jul-2020 09:38:00,2020-07-15 09:38:00,-,-,https://nsearchives.nseindia.com/corporate/DIVISLAB_15072020093852_Reg74_5_Divis_3062020.pdf,15-07-2020,2219.0,2245.0,2214.14990234375,2225.300048828125,2181.761962890625,1234453,0.0,0.0,22-07-2020,0
71,DIVISLAB,Divi's Laboratories Limited,updates," regarding 'intimation under regulation 30 of the sebi (listing obligations and disclosure requirements) regulations, 2015'.",02-Jul-2020 16:12:00,2020-07-02 16:12:00,-,-,https://nsearchives.nseindia.com/corporate/DIVISLAB_02072020161257_Regulation_30_intimation_02072020Divis.pdf,02-07-2020,2100.0,2242.0,2090.050048828125,2196.64990234375,2153.67236328125,4392566,0.0,0.0,09-07-2020,0
72,DIVISLAB,Divi's Laboratories Limited,trading window," regarding the trading window closure pursuant to sebi (prohibition of insider trading) regulations, 2015",30-Jun-2020 10:38:00,2020-06-30 10:38:00,-,-,https://nsearchives.nseindia.com/corporate/DIVISLAB_30062020103812_Notice_of_Trading_Window_Closure_01072020.pdf,30-06-2020,2334.949951171875,2334.949951171875,2267.0,2278.89990234375,2234.31298828125,684233,0.0,0.0,07-07-2020,0
73,DIVISLAB,Divi's Laboratories Limited,disclosure under sebi takeover regulations," regarding disclosure under regulations 31(4) of sebi (substantial acquisition of shares & takeovers) regulations, 2011",30-Apr-2020 13:37:00,2020-04-30 13:37:00,-,-,https://nsearchives.nseindia.com/corporate/DIVISLAB_30042020133745_DIVIS.pdf,30-04-2020,2365.0,2372.699951171875,2300.699951171875,2332.89990234375,2287.256591796875,843162,0.0,0.0,08-05-2020,0
74,DIVISLAB,Divi's Laboratories Limited,updates," regarding 'submission of certificate under regulation 74(5) of sebi (depositories and participants) regulations, 2018 for the quarter ended 31 march, 2020'.",17-Apr-2020 11:38:00,2020-04-17 11:38:00,-,-,https://nsearchives.nseindia.com/corporate/DIVISLAB_17042020113854_Reg74_5_Divis_31032020.pdf,17-04-2020,2430.0,2449.550048828125,2320.14990234375,2332.199951171875,2286.5703125,1326979,0.0,0.0,24-04-2020,0
75,DIVISLAB,Divi's Laboratories Limited,disclosure under sebi takeover regulations,"promoter of  regarding disclosure under regulation 30  of the sebi (substantial acquisition of shares and takeover) regulations, 2011",15-Apr-2020 08:57:00,2020-04-15 08:57:00,-,-,https://nsearchives.nseindia.com/corporate/DIVISLAB_15042020085759_DivisLaboratoriesLimited.pdf,15-04-2020,2371.0,2418.0,2330.0,2395.449951171875,2348.582763671875,1136701,0.0,0.0,22-04-2020,0
76,DIVISLAB,Divi's Laboratories Limited,updates," regarding 'update from divi s labs related to covid-19: operations, measures put in place, support to the nation - press release'.",01-Apr-2020 14:37:00,2020-04-01 14:37:00,-,-,https://nsearchives.nseindia.com/corporate/DIVISLAB_01042020143713_Press_Release_Divis_SE_01042020.pdf,01-04-2020,2000.0,2000.4000244140625,1844.25,1877.0,1840.2763671875,1165088,0.0,0.0,13-04-2020,1
77,DIVISLAB,Divi's Laboratories Limited,trading window," regarding the trading window closure pursuant to sebi (prohibition of insider trading) regulations, 2015",31-Mar-2020 12:09:00,2020-03-31 12:09:00,-,-,https://nsearchives.nseindia.com/corporate/DIVISLAB_31032020120929_Trading_Window_Closure_31032020.pdf,31-03-2020,1943.0,2035.0,1895.0,1989.050048828125,1950.1341552734373,937675,0.0,0.0,09-04-2020,1
78,DIVISLAB,Divi's Laboratories Limited,trading window," regarding the trading window closure pursuant to sebi (prohibition of insider trading) regulations, 2015",31-Mar-2020 12:02:00,2020-03-31 12:02:00,-,-,https://nsearchives.nseindia.com/corporate/DIVISLAB_31032020120256_Trading_Window_Closure_31032020.pdf,31-03-2020,1943.0,2035.0,1895.0,1989.050048828125,1950.1341552734373,937675,0.0,0.0,09-04-2020,1
79,DIVISLAB,Divi's Laboratories Limited,shareholders meeting,"divi's laboratories limited has submitted the exchange a copy srutinizers report of  postal ballot. further, the company has informed the exchange regarding voting results.",27-Feb-2020 17:26:00,2020-02-27 17:26:00,-,-,https://nsearchives.nseindia.com/corporate/DIVISLAB_27022020172605_PB_Voting_Results_27022020_Divis.pdf,27-02-2020,2148.0,2172.0,2117.050048828125,2156.550048828125,2114.35693359375,569625,0.0,0.0,05-03-2020,0
80,DIVISLAB,Divi's Laboratories Limited,updates, regarding 'newspaper advertisement - notice of record date for interim dividend '.,13-Feb-2020 14:14:00,2020-02-13 14:14:00,-,-,https://nsearchives.nseindia.com/corporate/DIVISLAB_13022020141403_NewspaperRecordDateNotice_Reg30_Divis_13022020.pdf,13-02-2020,2135.050048828125,2173.800048828125,2121.800048828125,2155.800048828125,2097.968505859375,591980,0.0,0.0,20-02-2020,0
81,DIVISLAB,Divi's Laboratories Limited,record date," that the company has fixed record date as february 26, 2020 for the purpose of interim dividend",12-Feb-2020 16:32:00,2020-02-12 16:32:00,-,-,https://nsearchives.nseindia.com/corporate/DIVISLAB_12022020163253_DIVISLAB_12022020162547.pdf,12-02-2020,2159.0,2179.949951171875,2112.0,2121.800048828125,2064.880615234375,984894,0.0,0.0,19-02-2020,0
82,DIVISLAB,Divi's Laboratories Limited,dividend," that board of directors at its meeting held on february 12, 2020, declared interim dividend of 16 per equity share.",12-Feb-2020 16:25:00,2020-02-12 16:25:00,-,-,https://nsearchives.nseindia.com/corporate/DIVISLAB_12022020162547_Outcome_Interim_Dividend_12022020_Divis.pdf,12-02-2020,2159.0,2179.949951171875,2112.0,2121.800048828125,2064.880615234375,984894,0.0,0.0,19-02-2020,0
83,DIVISLAB,Divi's Laboratories Limited,trading window," regarding the trading window closure pursuant to sebi (prohibition of insider trading) regulations, 2015",07-Feb-2020 12:38:00,2020-02-07 12:38:00,-,-,https://nsearchives.nseindia.com/corporate/DIVISLAB_07022020123805_Intimation_BoardMeeting_12022020_DivisLab.pdf,07-02-2020,2023.0,2095.0,2011.0,2085.949951171875,2029.9921875,890175,0.0,0.0,14-02-2020,0
84,DIVISLAB,Divi's Laboratories Limited,financial result updates,", the financial results for the period ended december 31, 2019.",05-Feb-2020 19:23:11,2020-02-05 19:23:11,-,-,https://nsearchives.nseindia.com/corporate/Results_Q3SE_Submission_DLL_05022020192311.zip,05-02-2020,1962.050048828125,1990.0,1946.199951171875,1962.6500244140625,1909.9998779296875,519051,0.0,0.0,12-02-2020,1
85,DIVISLAB,Divi's Laboratories Limited,updates," regarding 'us-fda inspection of unit -ii at village chippada, andhra pradesh'.",31-Jan-2020 17:52:00,2020-01-31 17:52:00,-,-,https://nsearchives.nseindia.com/corporate/DIVISLAB_31012020175234_Intimation_USFDA_31012020.pdf,31-01-2020,1969.0,1984.0,1948.0,1952.300048828125,1899.9276123046875,322232,0.0,0.0,07-02-2020,1
86,DIVISLAB,Divi's Laboratories Limited,updates," regarding 'newspaper advertisement confirming despatch of postal ballot notice dated 04 january, 2020 and giving details of e-voting'.",28-Jan-2020 10:44:00,2020-01-28 10:44:00,-,-,https://nsearchives.nseindia.com/corporate/DIVISLAB_28012020104351_Intimation_of_newspaper_publication28012020_postal_ballot_notice_018.pdf,28-01-2020,1918.3499755859373,1951.800048828125,1903.1500244140625,1946.75,1894.5263671875,527383,0.0,0.0,04-02-2020,0
87,DIVISLAB,Divi's Laboratories Limited,updates," regarding 'submission of certificate under regulation 74(5) of sebi (depositories and participants) regulations, 2018 for the quarter ended 31 december, 2019'.",20-Jan-2020 09:26:00,2020-01-20 09:26:00,-,-,https://nsearchives.nseindia.com/corporate/DIVISLAB_20012020092546_Certificate_74_5_31122019DIVIS_014.pdf,20-01-2020,1905.0,1926.4000244140625,1887.0999755859373,1892.0,1841.2451171875,420979,0.0,0.0,27-01-2020,0
88,DIVISLAB,Divi's Laboratories Limited,trading window," regarding the trading window closure pursuant to sebi (prohibition of insider trading) regulations, 2015",31-Dec-2019 08:50:00,2019-12-31 08:50:00,-,-,https://nsearchives.nseindia.com/corporate/DIVISLAB_31122019084930_Tradingwindowclosure31122019Divis_007.pdf,31-12-2019,1852.0,1857.199951171875,1835.0999755859373,1845.800048828125,1796.284423828125,287988,0.0,0.0,07-01-2020,0
89,DIVISLAB,Divi's Laboratories Limited,updates, regarding 'change of name of the share transfer agent of the company from  karvy fintech private limited  to  kfin technologies private limited'.,10-Dec-2019 09:58:00,2019-12-10 09:58:00,-,-,https://nsearchives.nseindia.com/corporate/DIVISLAB_10122019095748_RTA_name_change_006.pdf,10-12-2019,1810.0999755859373,1821.5999755859373,1795.4000244140625,1813.6500244140625,1764.9970703125,418388,0.0,0.0,17-12-2019,0
90,DIVISLAB,Divi's Laboratories Limited,related party transactions," regarding disclosure of related party transaction under regulation 23(9) of the sebi (listing obligations and disclosure requirements) regulations, 2015.",03-Dec-2019 12:55:00,2019-12-03 12:55:00,-,-,https://nsearchives.nseindia.com/corporate/listcontract1_3122019124955_RPT30092019Divis_093.pdf,03-12-2019,1795.0,1799.9000244140625,1779.949951171875,1795.1500244140625,1746.9931640625,263215,0.0,0.0,10-12-2019,0
91,DIVISLAB,Divi's Laboratories Limited,updates," regarding 'us-fda inspection of unit -i at village lingojigudem, bhuvanagiri yadadri district, telangana'.",15-Nov-2019 11:43:00,2019-11-15 11:43:00,-,-,https://nsearchives.nseindia.com/corporate/DIVISLAB_15112019114254_cs15112019_091.pdf,15-11-2019,1645.0,1758.949951171875,1627.0,1747.699951171875,1700.8160400390625,2475371,0.0,0.0,22-11-2019,0
92,DIVISLAB,Divi's Laboratories Limited,financial result updates,", the financial results for the period ended september 30, 2019.",05-Nov-2019 18:02:33,2019-11-05 18:02:33,-,-,https://nsearchives.nseindia.com/corporate/Q2results30092019DIVIS_05112019180233.zip,05-11-2019,1735.0,1738.25,1676.800048828125,1687.449951171875,1642.1822509765625,587695,0.0,0.0,13-11-2019,0
93,DIVISLAB,Divi's Laboratories Limited,updates," regarding 'submission of certificate under regulation 74(5) of sebi (depositories and participants) regulations, 2018 for the quarter ended 30 september, 2019'.",22-Oct-2019 14:40:00,2019-10-22 14:40:00,-,-,https://nsearchives.nseindia.com/corporate/DIVISLAB_22102019144042_Certificate_reg74_5_30092019_Divis_162.pdf,22-10-2019,1732.4000244140625,1773.550048828125,1726.25,1741.1500244140625,1694.4417724609375,814403,0.0,0.0,29-10-2019,0
94,DIVISLAB,Divi's Laboratories Limited,shareholders meeting,"divi's laboratories limited has submitted the exchange a copy srutinizers report of  postal ballot. further, the company has informed the exchange regarding voting results.",09-Oct-2019 14:50:00,2019-10-09 14:50:00,-,-,https://nsearchives.nseindia.com/corporate/DIVISLAB_09102019144801_PBresultsDivis09102019_151.pdf,09-10-2019,1650.550048828125,1655.0,1621.199951171875,1650.5999755859375,1606.32080078125,248324,0.0,0.0,16-10-2019,0
95,DIVISLAB,Divi's Laboratories Limited,trading window," regarding the trading window closure pursuant to sebi (prohibition of insider trading) regulations, 2015",27-Sep-2019 16:24:00,2019-09-27 16:24:00,-,-,https://nsearchives.nseindia.com/corporate/DIVISLAB_27092019162353_TradingwindowClosure_333.pdf,27-09-2019,1671.0,1696.9000244140625,1655.25,1660.449951171875,1615.9066162109375,659001,0.0,0.0,07-10-2019,0
96,DIVISLAB,Divi's Laboratories Limited,updates, regarding 'newspaper advertisement confirming despatch of postal ballot notice and e-voting details - published on 08 september 2019'.,09-Sep-2019 14:03:00,2019-09-09 14:03:00,-,-,https://nsearchives.nseindia.com/corporate/DIVISLAB_09092019140238_IntimationOfNewsPaperAdDivis09092019_196.pdf,09-09-2019,1636.0,1653.6500244140625,1617.0,1627.1500244140625,1583.5,405327,0.0,0.0,17-09-2019,0
97,DIVISLAB,Divi's Laboratories Limited,updates, regarding 'newspaper advertisement confirming despatch of postal ballot notice and e-voting details'.,09-Sep-2019 13:53:00,2019-09-09 13:53:00,-,-,https://nsearchives.nseindia.com/corporate/DIVISLAB_09092019135245_IntimationOfNewsPaperAdDivis09092019_192.pdf,09-09-2019,1636.0,1653.6500244140625,1617.0,1627.1500244140625,1583.5,405327,0.0,0.0,17-09-2019,0
98,DIVISLAB,Divi's Laboratories Limited,updates," regarding 'inspection of unit-ii by ema'.divi's laboratories limited, unit-2 vishakhapatnam has been inspected by 5 inspectors from hpra (ireland) and jazmp (slovenia) from 26th august, 2019 to                    30th august, 2019.the inspection at site was focused on general gmp.the inspection has concluded successfully with no critical observations.",30-Aug-2019 17:25:00,2019-08-30 17:25:00,-,-,https://nsearchives.nseindia.com/corporate/DIVISLAB_30082019172341_Update_EMA_Inspection_321.pdf,30-08-2019,1611.5999755859375,1643.3499755859375,1601.449951171875,1625.4000244140625,1581.797119140625,357258,0.0,0.0,09-09-2019,0
99,DIVISLAB,Divi's Laboratories Limited,shareholders meeting," regarding proceedings of annual general meeting held on august 23, 2019",23-Aug-2019 17:43:00,2019-08-23 17:43:00,-,-,https://nsearchives.nseindia.com/corporate/DIVISLAB_23082019174232_Out_come_of_AGM_Divis_23082019_280.pdf,23-08-2019,1564.949951171875,1577.449951171875,1540.550048828125,1571.5999755859375,1529.440185546875,469022,0.0,0.0,30-08-2019,0
100,DIVISLAB,Divi's Laboratories Limited,updates," regarding 'compliance of regulation 30(5) of sebi (listing obligations and disclosure requirements) regulations, 2015'.",20-Aug-2019 11:45:00,2019-08-20 11:45:00,-,-,https://nsearchives.nseindia.com/corporate/DIVISLAB_20082019114445_Intimation_Reg30_044.pdf,20-08-2019,1518.0999755859375,1541.949951171875,1516.199951171875,1522.1500244140625,1481.3167724609375,382353,0.0,0.0,27-08-2019,0
101,DIVISLAB,Divi's Laboratories Limited,shareholders meeting," regarding notice of annual general meeting to be held on august 23, 2019",25-Jul-2019 13:38:00,2019-07-25 13:38:00,-,-,https://nsearchives.nseindia.com/corporate/DIVISLAB_25072019133809_AnnualReport_2018_19DIVIS_113.pdf,25-07-2019,1604.0,1649.949951171875,1603.0,1641.75,1580.93896484375,382130,0.0,0.0,01-08-2019,0
102,DIVISLAB,Divi's Laboratories Limited,agm/book closure," that the register of members and share transfer books of the company will remain closed from august 17, 2019 to august 23, 2019 ( both days inclusive) for the purpose of annual general meeting and payment of dividend.",25-Jul-2019 09:56:00,2019-07-25 09:56:00,-,-,https://nsearchives.nseindia.com/corporate/listcontract3_25072019095235_DIVISLAB_017.pdf,25-07-2019,1604.0,1649.949951171875,1603.0,1641.75,1580.93896484375,382130,0.0,0.0,01-08-2019,0
103,DIVISLAB,Divi's Laboratories Limited,change in company secretary/compliance officer," about appointment of mr. m. satish choudhury as compliance officer of the company in place of interim compliance officer ms. deepa kumari with effect from 19 july, 2019.",19-Jul-2019 16:58:00,2019-07-19 16:58:00,-,-,https://nsearchives.nseindia.com/corporate/DIVISLAB_19072019165703_Reg_30_Compaliance_Officer_231.pdf,19-07-2019,1644.0999755859375,1659.9000244140625,1620.050048828125,1624.4000244140625,1564.2315673828125,464691,0.0,0.0,26-07-2019,0
104,DIVISLAB,Divi's Laboratories Limited,trading window," regarding the trading window closure pursuant to sebi (prohibition of insider trading) regulations, 2015 from july 01, 2019 till 48 hours after the declaration of the financial results for the quarter ended june 30, 2019.",27-Jun-2019 16:19:00,2019-06-27 16:19:00,-,-,https://nsearchives.nseindia.com/corporate/DIVISLAB_27062019161628_Trading_Window_Closure_180.pdf,27-06-2019,1595.0,1608.0,1578.0,1601.800048828125,1542.4686279296875,511835,0.0,0.0,04-07-2019,0
105,DIVISLAB,Divi's Laboratories Limited,related party transactions," a copy of revised half yearly disclosure on related party transactions for the period ended march 31, 2019.",17-Jun-2019 10:26:00,2019-06-17 10:26:00,-,-,https://nsearchives.nseindia.com/corporate/listcontract1_1762019892_Reg_RPT_23_9_Revised_079.pdf,17-06-2019,1539.300048828125,1582.9000244140625,1532.4000244140625,1540.5,1483.4390869140625,1053764,0.0,0.0,24-06-2019,0
106,DIVISLAB,Divi's Laboratories Limited,related party transactions," a copy of half yearly disclosure on related party transactions for the half year ended march 31, 2019.",17-Jun-2019 09:46:00,2019-06-17 09:46:00,-,-,https://nsearchives.nseindia.com/corporate/listcontract1_176201983051_RPT_Reg_29_3_053.pdf,17-06-2019,1539.300048828125,1582.9000244140625,1532.4000244140625,1540.5,1483.4390869140625,1053764,0.0,0.0,24-06-2019,0
107,DIVISLAB,Divi's Laboratories Limited,dividend," that the board of directors of the company at its meeting held on may 25, 2019 has recommended dividend@ 800% i.e rs. 16/- per equity share of face valuers. 2/- each for the financial year 2018-19.",27-May-2019 09:29:00,2019-05-27 09:29:00,-,-,https://nsearchives.nseindia.com/corporate/listcontract1_25052019152002_DIVISLAB_034.pdf,27-05-2019,1729.5,1730.050048828125,1578.050048828125,1593.449951171875,1534.427734375,3084161,0.0,0.0,03-06-2019,0
108,DIVISLAB,Divi's Laboratories Limited,disc. under reg.30 of sebi (sast) reg.2011,"the promoter along with pac has submitted to the exchange a copy of annual disclosure under regulation 30(1) and 30(2) of sebi (substantial acquisition of shares and takeovers), regulations, 2011 as on march 31, 2019.",08-Apr-2019 15:19:00,2019-04-08 15:19:00,-,-,https://nsearchives.nseindia.com/corporate/listcontract1_08042019132102_Divi_258.pdf,08-04-2019,1714.699951171875,1719.0,1677.199951171875,1684.449951171875,1622.0572509765625,461738,0.0,0.0,15-04-2019,0
109,DIVISLAB,Divi's Laboratories Limited,trading window," regarding the trading window closure pursuant to sebi (prohibition of insider trading) regulations, 2015",03-Apr-2019 11:28:00,2019-04-03 11:28:00,-,-,https://nsearchives.nseindia.com/corporate/DIVISLAB_03042019112751_Trading_window_closure_059.pdf,03-04-2019,1707.550048828125,1707.550048828125,1665.449951171875,1675.800048828125,1613.7276611328125,393202,0.0,0.0,10-04-2019,0
110,DIVISLAB,Divi's Laboratories Limited,appointment," regarding appointment of ms prof sunaina singh as additional ( independent) director of the company w.e.f. march 28, 2019.",28-Mar-2019 13:16:00,2019-03-28 13:16:00,-,-,https://nsearchives.nseindia.com/corporate/DIVISLAB_28032019131524_Outcome_BM_069.pdf,28-03-2019,1669.9000244140625,1699.0,1641.5,1654.550048828125,1593.2647705078125,1681103,0.0,0.0,05-04-2019,0
111,DIVISLAB,Divi's Laboratories Limited,shareholders meeting,"divi's laboratories limited has submitted the exchange a copy srutinizers report of  postal ballot. further, the company has informed the exchange regarding voting results.",18-Mar-2019 15:48:00,2019-03-18 15:48:00,-,-,https://nsearchives.nseindia.com/corporate/DIVISLAB_18032019154633_Postal_Ballot_Voting_Results_114.pdf,18-03-2019,1718.0,1722.550048828125,1684.0999755859375,1689.3499755859375,1626.7757568359375,464384,0.0,0.0,26-03-2019,0
112,DIVISLAB,Divi's Laboratories Limited,news verification,"the exchange has sought clarification from divi's laboratories limited with respect to recent news item captioned ￂﾓ income tax raids conducted at coￂﾒs offices in telengana & andhra pradesh ￂﾔ. the exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. divi's laboratories limited has submitted their response.",18-Feb-2019 18:51:00,2019-02-18 18:51:00,-,-,https://nsearchives.nseindia.com/corporate/mjain_18022019184042_DIVISLAB_7940_reply_266.pdf,18-02-2019,1617.9000244140625,1621.050048828125,1559.0,1574.75,1516.420654296875,890862,0.0,0.0,25-02-2019,0
113,DIVISLAB,Divi's Laboratories Limited,shareholders meeting,"divi's laboratories limited has submitted the exchange a copy srutinizers report of  annual general meeting held on september 10, 2018. further, the company has informed the exchange regarding voting results.",11-Sep-2018 12:30:00,2018-09-11 12:30:00,-,-,https://nsearchives.nseindia.com/corporate/DIVISLAB_11092018122835_AGM_Voting_Results_058.pdf,11-09-2018,1278.800048828125,1290.25,1232.800048828125,1244.6500244140625,1198.547607421875,837631,0.0,0.0,19-09-2018,1
114,DIVISLAB,Divi's Laboratories Limited,shareholders meeting," regarding proceedings of annual general meeting held on september 10, 2018",10-Sep-2018 14:22:00,2018-09-10 14:22:00,-,-,https://nsearchives.nseindia.com/corporate/DIVISLAB_10092018142013_AGM_OUTCOME10092018_347.pdf,10-09-2018,1312.9000244140625,1329.0,1268.050048828125,1278.800048828125,1231.4327392578125,826691,0.0,0.0,18-09-2018,1
115,DIVISLAB,Divi's Laboratories Limited,updates, regarding 'newspaper advertisement confirming dispatch of notice of 28th annual general meeting '.,07-Aug-2018 12:31:00,2018-08-07 12:31:00,-,-,https://nsearchives.nseindia.com/corporate/Newspaperadd_07082018123126_704.zip,07-08-2018,1196.0,1199.9000244140625,1151.5999755859375,1162.5,1110.8349609375,859756,0.0,0.0,14-08-2018,0
116,DIVISLAB,Divi's Laboratories Limited,shareholders meeting," regarding notice of annual general meeting to be held on september 10, 2018",06-Aug-2018 14:15:00,2018-08-06 14:15:00,-,-,https://nsearchives.nseindia.com/corporate/Notice_AGM2018_06082018141525_148.zip,06-08-2018,1205.0,1221.9000244140625,1160.0,1192.699951171875,1139.6927490234375,2336944,0.0,0.0,13-08-2018,-1
117,DIVISLAB,Divi's Laboratories Limited,agm/book closure," that the register of members and share transfer books of the company shall remain closed from  september 4, 2018 to september 10, 2018 (both days inclusive) for  the purpose of the annual general meeting going to be held on september 10, 2018 and payment of dividend, if declared at the ensuing annual general meeting.",30-Jul-2018 12:51:00,2018-07-30 12:51:00,-,-,https://nsearchives.nseindia.com/corporate/Intimation_of_BookClosure_30072018125145_847.zip,30-07-2018,1102.0,1163.449951171875,1091.25,1156.5999755859375,1105.197021484375,2177271,0.0,0.0,06-08-2018,0
118,DIVISLAB,Divi's Laboratories Limited,updates," regarding 'pursuant to regulation 30 of the sebi (listing obligations and disclosure requirements) regulations, 2015, we are enclosing herewith copies of notice to shareholders of the company intimating that equity shares in respect of which dividend remain unclaimed for seven consecutive years would be transferred to investor education and protection fund (iepf) authority. this notice was published on 4th july, 2018 in the following newspapers:ￂﾕ financial express (english daily)ￂﾕ andhra prabha (telugu daily)'.",04-Jul-2018 12:44:00,2018-07-04 12:44:00,-,-,https://nsearchives.nseindia.com/corporate/Notice_04072018124421_394.zip,04-07-2018,1086.0,1105.949951171875,1072.0,1102.300048828125,1053.310546875,1347815,0.0,0.0,11-07-2018,0
119,DIVISLAB,Divi's Laboratories Limited,updates," regarding 'diviￂﾒs laboratories hereby announces that its unit-i at choutuppal, telangana state has had an inspection by the us-fda from 14th may 2018 to 16th may, 2018. this was a general cgmp inspection by the fda. the inspection has been concluded with no 483 observations.'.",16-May-2018 16:32:00,2018-05-16 16:32:00,-,-,https://nsearchives.nseindia.com/corporate/Announcement_USFDA_Inspection_16052018163227_349.zip,16-05-2018,1148.0,1171.0,1139.050048828125,1165.1500244140625,1113.3671875,531175,0.0,0.0,23-05-2018,-1
120,DIVISLAB,Divi's Laboratories Limited,updates," regarding 'we had earlier informed the exchanges vide our letter of 2nd november, 2017 that the us-fda will be lifting the import alert 66-40 imposed on the companyￂﾒs unit-ii at visakhapatnam.the fdaￂﾒs website has now been updated on 14th november, 2017 and the import alert 66-40 on the companyￂﾒs unit-ii has been removed'.",15-Nov-2017 08:44:00,2017-11-15 08:44:00,-,-,https://nsearchives.nseindia.com/corporate/Update_US_FDA_15112017084447_263.zip,15-11-2017,1059.0,1059.0,1011.0,1015.7000122070312,970.5592651367188,1262085,0.0,0.0,22-11-2017,0
121,DIVISLAB,Divi's Laboratories Limited,updates," regarding 'further to our letter dated 2nd november, 2017, diviￂﾒs laboratories has been informed by the us-fda that the agency has completed evaluation of the companyￂﾒs corrective actions in response to fdaￂﾒs warning letter: 320-17-34 dated april 13, 2017.  we also note from the update on fdaￂﾒs website that they have closed-out the warning letter.'.",10-Nov-2017 09:07:00,2017-11-10 09:07:00,-,-,https://nsearchives.nseindia.com/corporate/Update_US_FDA_10112017090715_022.zip,10-11-2017,1052.0,1089.0,1011.8499755859376,1016.4000244140624,971.2281494140624,2507352,0.0,0.0,17-11-2017,0
122,DIVISLAB,Divi's Laboratories Limited,updates, regarding 'diviￂﾒs laboratories has been informed by the us-fda that it will be lifting the import alert 66-40 and moving to close out the warning letter issued to the companyￂﾒs unit-ii at visakhapatnam.'.,02-Nov-2017 08:38:00,2017-11-02 08:38:00,-,-,https://nsearchives.nseindia.com/corporate/Updates_US_FDA_02112017083839_297.zip,02-11-2017,1016.0,1117.5999755859375,1016.0,1072.9000244140625,1025.21728515625,10648166,0.0,0.0,09-11-2017,-1
123,DIVISLAB,Divi's Laboratories Limited,financial result updates,", the financial results for the period ended september 30, 2017.",31-Oct-2017 18:41:31,2017-10-31 18:41:31,-,-,https://nsearchives.nseindia.com/corporate/Unaudited_Results_30092017_31102017184131.zip,31-10-2017,873.9500122070312,892.4000244140625,870.0999755859375,882.5,843.2791137695312,1410837,0.0,0.0,07-11-2017,1
124,DIVISLAB,Divi's Laboratories Limited,shareholders meeting,"divi's laboratories limited has submitted the exchange a copy srutinizers report of  annual general meeting held on september 25, 2017. further, the company has informed the exchange regarding voting results.",26-Sep-2017 14:39:00,2017-09-26 14:39:00,-,-,https://nsearchives.nseindia.com/corporate/AGM_Voting_Results_26092017143938_170.zip,26-09-2017,942.0,978.0,942.0,960.1500244140624,917.4780883789062,3559032,0.0,0.0,04-10-2017,-1
125,DIVISLAB,Divi's Laboratories Limited,shareholders meeting," regarding proceedings of annual general meeting held on september 25, 2017",25-Sep-2017 15:14:00,2017-09-25 15:14:00,-,-,https://nsearchives.nseindia.com/corporate/AGM_Proceedings_25092017151454_194.zip,25-09-2017,969.7999877929688,972.0,930.4500122070312,952.7000122070312,910.3591918945312,4565575,0.0,0.0,03-10-2017,-1
126,DIVISLAB,Divi's Laboratories Limited,updates," regarding 'we wish to inform that diviￂﾒs laboratories limited, unit-2 has been inspected by us-fda from september 11 to september 19, 2017.this inspection was for full cgmp and verification of all corrective actions proposed against the previous inspection observations. diviￂﾒs laboratories limited announces that all previous observations have been confirmed as completed and resolved. on completion of this inspection, diviￂﾒs laboratories limited has received a form 483 citing six observations which are procedural and the company will be responding to these within the stipulated time.disclaimer:this is to inform that the statements in this document relating to the estimates or events may be ￂﾓforward looking statementsￂﾔ within the meaning of the applicable securities regulations. actual results, performance or events, financial or non-financial, could differ materially from those expressed or implied.'.",20-Sep-2017 10:52:00,2017-09-20 10:52:00,-,-,https://nsearchives.nseindia.com/corporate/Update_20092017105232_056.zip,20-09-2017,874.0,948.9000244140624,865.5999755859375,942.7999877929688,900.899169921875,18987654,0.0,0.0,27-09-2017,-1
127,DIVISLAB,Divi's Laboratories Limited,updates," regarding ' notice of the 27th annual general meeting of the company scheduled to be held on monday, the 25th day of september 2017 at 10.00 a.m. at global peace auditorium, brahma kumaris, shanti sarovar, academy for better world, gachibowli, hyderabad   500 032. '.",30-Aug-2017 10:21:00,2017-08-30 10:21:00,-,-,https://nsearchives.nseindia.com/corporate/Notice_of_27th_AGM_30082017102159_243.zip,30-08-2017,692.1500244140625,709.0,692.1500244140625,702.5999755859375,663.6577758789062,1072727,0.0,0.0,06-09-2017,0
128,DIVISLAB,Divi's Laboratories Limited,agm/book closure," that the register of members and share transfer books of the company will remain closed from  september 19, 2017 to  september 25, 2017 (both days inclusive) for the purpose of the annual general meeting of the company and payment of dividend, if declared at the ensuing annual general meeting to be held on september 25, 2017.",21-Aug-2017 11:32:00,2017-08-21 11:32:00,-,-,https://nsearchives.nseindia.com/corporate/DIVISLAB_21082017113233.zip,21-08-2017,637.0999755859375,639.25,618.2000122070312,622.1500244140625,587.6669311523438,310755,0.0,0.0,29-08-2017,1
129,DIVISLAB,Divi's Laboratories Limited,updates," that divi s laboratories limited, unit-2 vishakhapatnam has been inspected by 5 inspectors from hpra (ireland) and jazmp (slovenia) from july 31, 2017 to august 4, 2017. the inspection was focused on: 1) follow up on the effectiveness of the capa s implemented from the last jazmp inspection 2) general gmp inspection of the site the inspection has concluded successfully with no critical observations.",04-Aug-2017 14:47:00,2017-08-04 14:47:00,-,-,https://nsearchives.nseindia.com/corporate/EMA_Announcement_04082017144706_264.zip,04-08-2017,669.0499877929688,699.9500122070312,660.0,682.1500244140625,644.34130859375,1211462,0.0,0.0,11-08-2017,-1
130,DIVISLAB,Divi's Laboratories Limited,updates, regarding usfda to lift import alert 99-32 on the company's unit-ii at visakhapatnam.,10-Jul-2017 11:57:00,2017-07-10 11:57:00,-,-,https://nsearchives.nseindia.com/corporate/FDA_Updates_10072017115719_114.zip,10-07-2017,726.0,748.0,725.0,735.4000244140625,694.6400146484375,1281487,0.0,0.0,17-07-2017,0
131,DIVISLAB,Divi's Laboratories Limited,outcome of board meeting," regarding outcome of board meeting held on jun 27, 2017.pursuant to regulation 30 of sebi (listing obligations and disclosure requirements) regulations, 2015, we wish to inform you that the board of directors at their meeting held on 27th june, 2017 has:1) noted the completion of tenure of mrs. s. sridevi as an independent director of the company w.e.f. 22nd june, 2017 and hence she ceases to be a director of the company.  the board places on record its appreciation of the contribution made by mrs. sridevi during her tenure.2) appointed dr. ramesh b. v. nimmagadda as an additional (independent) director w.e.f. 27th june, 20173) appointed ms. nilima motaparti, as an additional (whole-time) director w.e.f. 27th june, 2017, who was earlier appointed by the members as chief controller (commercial) in the year 2012.4) noted that the term of the present statutory auditors m/s. pvrk nageswara rao & co., expires at the conclusion of the ensuing 27th annual general meeting of the company as per section 139 of the companies act, 2013, and are not eligible for re-appointment.5) recommended appointment of m/s. price waterhouse, chartered accountants, as statutory auditors of the company for a term of 5 consecutive years from the conclusion of the 27th annual general meeting of the company scheduled to be held in the year 2017 till the conclusion of 32nd annual general meeting, for approval of the members of the company.",28-Jun-2017 10:52:00,2017-06-28 10:52:00,-,-,https://nsearchives.nseindia.com/corporate/Appointment_Directors_and_Auditors_28062017105211_312.zip,28-06-2017,641.5,645.0,637.25,641.0,605.4721069335938,409519,0.0,0.0,05-07-2017,0
132,DIVISLAB,Divi's Laboratories Limited,dividend," that board of directors at its meeting held on may 26, 2017, recommended final dividend of rs. 10 per equity share.",26-May-2017 18:16:00,2017-05-26 18:16:00,-,-,https://nsearchives.nseindia.com/corporate/AuditedFinancialResults31032017_26052017181655_951.zip,26-05-2017,548.0,561.0,542.5,545.2999877929688,515.0763549804688,1229349,0.0,0.0,02-06-2017,1
133,DIVISLAB,Divi's Laboratories Limited,financial result updates,", the financial results for the period ended march 31, 2017.",26-May-2017 18:06:03,2017-05-26 18:06:03,-,-,https://nsearchives.nseindia.com/corporate/AuditedFinancialResults31032017_26052017180603.zip,26-05-2017,548.0,561.0,542.5,545.2999877929688,515.0763549804688,1229349,0.0,0.0,02-06-2017,1
134,DIVISLAB,Divi's Laboratories Limited,disc. under reg.30 of sebi (sast) reg.2011,"dr. murali divi has submitted to the exchange a copy of disclosure under regulation 30(1) and 30(2) of sebi (substantial acquisition of shares & takeovers) regulations, 2011.",10-Apr-2017 19:25:00,2017-04-10 19:25:00,-,-,https://nsearchives.nseindia.com/corporate/divilabs_10042017192540.zip,10-04-2017,656.0,661.0,642.2000122070312,658.0999755859375,621.6243286132812,5746326,0.0,0.0,18-04-2017,0
135,DIVISLAB,Divi's Laboratories Limited,updates," regarding update that the import alert by us-fda for the products manufactured at the company's unit-ii at visakhapatnam , andhra pradesh.",22-Mar-2017 16:39:00,2017-03-22 16:39:00,-,-,https://nsearchives.nseindia.com/corporate/UPDATEonimportalert_22032017163927_948.zip,22-03-2017,620.0,639.5999755859375,611.4500122070312,627.0,592.2481079101562,9453821,0.0,0.0,29-03-2017,0
136,DIVISLAB,Divi's Laboratories Limited,updates," vide letter dated march 21, 2017 regarding "" import alert 66-40 issued by us-fda on products manufactured at the company's unit -ii at visakhapatnam, andhra pradesh"".",21-Mar-2017 08:51:00,2017-03-21 08:51:00,-,-,https://nsearchives.nseindia.com/corporate/AnnouncementonImportAlert_21032017085120_373.zip,21-03-2017,711.5999755859375,711.5999755859375,628.5999755859375,634.4500122070312,599.2850952148438,20647975,0.0,0.0,28-03-2017,0
137,DIVISLAB,Divi's Laboratories Limited,updates," vide letter dated january 09, 2017, regarding ""update on us-fda inspection of our unit-ii at visakhapatnam"".",09-Jan-2017 09:50:00,2017-01-09 09:50:00,-,-,https://nsearchives.nseindia.com/corporate/Updates_09012017095048_150.zip,09-01-2017,733.75,767.0499877929688,728.1500244140625,734.1500244140625,693.459228515625,5617248,0.0,0.0,16-01-2017,0
138,DIVISLAB,Divi's Laboratories Limited,news verification,"the exchange has sought clarification from divi's laboratories limited with respect to recent news item captioned ""emkay says on vizag 483 observation: 1. proper control not being exercised over computer system 2. facility equipments not maintained to ensure purity quality strength 3. documentation and records not maintained or inaccurate falsified."" the exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. divi's laboratories limited has submitted their response.",23-Dec-2016 16:00:00,2016-12-23 16:00:00,-,-,https://nsearchives.nseindia.com/corporate/DIVISLAB_6565_reply_23122016160028.zip,23-12-2016,1100.5,1108.199951171875,801.0999755859375,861.5,813.7507934570312,13374164,0.0,0.0,30-12-2016,-1
139,DIVISLAB,Divi's Laboratories Limited,updates," that it s unit-ii at visakhapatnam, andhra pradesh has had an inspection by the us-fda from november 29, 2016 to december 06, 2016. the company have been issued a form 483 with 5 observations and these shall be responded within the time permitted.",07-Dec-2016 16:23:00,2016-12-07 16:23:00,-,-,https://nsearchives.nseindia.com/corporate/DivisUSFDA_07122016162323_581.zip,07-12-2016,1162.0,1166.0,1140.800048828125,1160.75,1096.4146728515625,384693,0.0,0.0,14-12-2016,0
140,DIVISLAB,Divi's Laboratories Limited,updates," a copy of the notice sent to shareholders of the company in respect of transfer of equity shares of the company to investor education and protection fund (iepf) suspense account, published in newspapers.",30-Nov-2016 10:51:00,2016-11-30 10:51:00,-,-,https://nsearchives.nseindia.com/corporate/LettertoSEs_30112016105132_369.zip,30-11-2016,1174.449951171875,1189.800048828125,1163.0,1174.0,1108.93017578125,519489,0.0,0.0,07-12-2016,0
141,DIVISLAB,Divi's Laboratories Limited,news clarification," vide letter dated august 31, 2016 regarding ""clarification on news on import alert from us fda"".",31-Aug-2016 18:16:00,2016-08-31 18:16:00,-,-,https://nsearchives.nseindia.com/corporate/ClarificationLetter_31082016181620_932.zip,31-08-2016,1315.0,1335.0999755859375,1311.5999755859375,1322.5,1249.199462890625,635036,0.0,0.0,08-09-2016,0
142,DIVISLAB,Divi's Laboratories Limited,"regulation 44(3) of sebi (lodr), reg., 2015"," a copy of voting results of annual general meeting of the company held on august 29, 2016, along with a copy of scrutinizer's report.",30-Aug-2016 16:00:00,2016-08-30 16:00:00,-,-,https://nsearchives.nseindia.com/corporate/AGMvotingresults_30082016160007_192.zip,30-08-2016,1310.050048828125,1339.5,1303.550048828125,1314.050048828125,1241.218017578125,483127,0.0,0.0,07-09-2016,0
143,DIVISLAB,Divi's Laboratories Limited,annual general meeting updates," a copy of the proceedings of the annual general meeting of the company held on august 29, 2016 along with chairman speech.",29-Aug-2016 14:29:00,2016-08-29 14:29:00,-,-,https://nsearchives.nseindia.com/corporate/AGMproceedings_29082016142927_476.zip,29-08-2016,1335.0999755859375,1344.699951171875,1294.199951171875,1303.300048828125,1231.0635986328125,396327,0.0,0.0,06-09-2016,0
144,DIVISLAB,Divi's Laboratories Limited,press release," regarding a press release dated august 12, 2016 with respect to the unaudited financial results for the quarter ended june 30, 2016.",12-Aug-2016 18:16:00,2016-08-12 18:16:00,-,-,https://nsearchives.nseindia.com/corporate/DIVISLAB_pres_12082016181652.zip,12-08-2016,1180.050048828125,1199.75,1173.0,1194.050048828125,1127.8687744140625,444729,0.0,0.0,22-08-2016,1
145,DIVISLAB,Divi's Laboratories Limited,outcome of board meeting," that the board of directors of the company, at their meeting held on august 12, 2016, have approved and ratified one-time ex-gratia of an aggregate amount of rs.79 crores to the employees and whole-time directors of the company on the occasion of completion of 25 years of formation of the company. this amount will be reflected in the financial results for the 2nd quarter of the current financial year.",12-Aug-2016 18:14:00,2016-08-12 18:14:00,-,-,https://nsearchives.nseindia.com/corporate/outcome_12082016181420_306.zip,12-08-2016,1180.050048828125,1199.75,1173.0,1194.050048828125,1127.8687744140625,444729,0.0,0.0,22-08-2016,1
146,DIVISLAB,Divi's Laboratories Limited,financial result updates," the standalone financial results along with the limited review report for the period ended june 30, 2016.",12-Aug-2016 17:55:44,2016-08-12 17:55:44,-,-,https://nsearchives.nseindia.com/corporate/Unauditedresults30062016_12082016175544.zip,12-08-2016,1180.050048828125,1199.75,1173.0,1194.050048828125,1127.8687744140625,444729,0.0,0.0,22-08-2016,1
147,DIVISLAB,Divi's Laboratories Limited,annual general meeting updates," a copy of notice of annual general meeting of the members of the company to be held on  august 29, 2016.",04-Aug-2016 10:17:00,2016-08-04 10:17:00,-,-,https://nsearchives.nseindia.com/corporate/NoticeOf26thAnnualGeneralMeeting_04082016101722_031.zip,04-08-2016,1175.699951171875,1185.0,1141.0,1150.75,1086.9688720703125,228739,0.0,0.0,11-08-2016,0
148,DIVISLAB,Divi's Laboratories Limited,agm/book closure," that the register of members & share transfer books of the company will remain closed from august 22, 2016 to august 26, 2016 (both days inclusive) for the purpose of annual general meeting (agm) of the company to be held on august 29, 2016.",29-Jul-2016 13:53:00,2016-07-29 13:53:00,-,-,https://nsearchives.nseindia.com/corporate/DIVISLAB_29072016135306.zip,29-07-2016,1197.0,1210.0,1192.9000244140625,1198.5,1132.0723876953125,390486,0.0,0.0,05-08-2016,0
149,DIVISLAB,Divi's Laboratories Limited,trading window," that the trading window for dealing in securities of the company shall remain closed for insiders of the company from may 21, 2016 to may 30, 2016 (both days inclusive) as per the code of conduct of the company under the sebi (prohibition of insider trading) regulations, 2015.",18-May-2016 12:18:00,2016-05-18 12:18:00,-,-,https://nsearchives.nseindia.com/corporate/Divis_18052016121824.zip,18-05-2016,1084.0,1089.949951171875,1068.0,1070.6500244140625,1011.3085327148438,224889,0.0,0.0,25-05-2016,0
150,DIVISLAB,Divi's Laboratories Limited,disc. under reg.30 of sebi (sast) reg.2011,"dr. murali k divi has submitted to the exchange vide letter dated april 04, 2016 a copy of disclosure under regulation 30(1) and 30(2) of sebi (substantial acquisition of shares & takeovers) regulations, 2011.",04-Apr-2016 12:24:00,2016-04-04 12:24:00,-,-,https://nsearchives.nseindia.com/corporate/Divis_30_04042016122437.zip,04-04-2016,1010.0499877929688,1013.9000244140624,990.75,1010.5999755859376,954.586669921875,112395,0.0,0.0,11-04-2016,0
151,DIVISLAB,Divi's Laboratories Limited,dividend," that the board of directors in its meeting held on march 10 2016 has declared an interim dividend @ rs.10/- per equity share of face value of rs.2/- each for the financial year 2015-16. the interim dividend will be credited / dispatched on or before march 29, 2016.",10-Mar-2016 13:00:00,2016-03-10 13:00:00,-,-,https://nsearchives.nseindia.com/corporate/OutcomeOfBM_10032016130059_840.zip,10-03-2016,1010.0,1027.699951171875,1002.0,1016.4000244140624,950.22705078125,262703,0.0,0.0,17-03-2016,0
152,DIVISLAB,Divi's Laboratories Limited,record date," that the company has fixed record date as march 18, 2016 for the purpose of interim dividend.",02-Mar-2016 15:06:00,2016-03-02 15:06:00,-,-,https://nsearchives.nseindia.com/corporate/DIVILAB_BM_02032016150626.zip,02-03-2016,963.0,996.4000244140624,957.9500122070312,970.4500122070312,907.2686767578124,616872,0.0,0.0,10-03-2016,0
153,DIVISLAB,Divi's Laboratories Limited,trading window," that the trading window for dealing in securities of the company shall remain closed for insiders of the company from march 3, 2016 to march 12, 2016 (both days inclusive) as per the code of conduct of the company under the sebi (prohibition of insider trading) regulations, 2015.",02-Mar-2016 15:00:00,2016-03-02 15:00:00,-,-,https://nsearchives.nseindia.com/corporate/DIVILAB_BM_02032016150059.zip,02-03-2016,963.0,996.4000244140624,957.9500122070312,970.4500122070312,907.2686767578124,616872,0.0,0.0,10-03-2016,0
154,DIVISLAB,Divi's Laboratories Limited,updates," that it has had a successful inspection by the us-fda for its unit-2 at chippada, bheemunipatnam near visakhapatnam during february, 2016 with no observations.",19-Feb-2016 16:04:00,2016-02-19 16:04:00,-,-,https://nsearchives.nseindia.com/corporate/NSE_19022016160424_402.zip,19-02-2016,975.5,1001.0,960.75,995.6500244140624,930.8280029296876,212929,0.0,0.0,26-02-2016,-1
155,DIVISLAB,Divi's Laboratories Limited,outcome of board meeting," that the board of directors of the company at its meeting held on february 05 2016, has approved to shift the registered office of the company from 7-1-77/e/1/303, divi towers, dharam karan road, ameerpet, hyderabad 500 016 to 1-72/23(p)/divis/303, divi towers, cyber hills, gachibowli, hyderabad 500 032 w.e.f february 05, 2016. the new registered office is within the local limits of the city.",05-Feb-2016 15:55:00,2016-02-05 15:55:00,-,-,https://nsearchives.nseindia.com/corporate/OutcomeofBMnse_05022016155557_161.zip,05-02-2016,1083.0,1120.0,1074.4000244140625,1110.449951171875,1038.1539306640625,474625,0.0,0.0,12-02-2016,-1
156,DIVISLAB,Divi's Laboratories Limited,press release," regarding a press release dated february 05, 2016, titled, ""divi's labs earns a pat of rs.247 crores in q3/fy16"".",05-Feb-2016 15:42:00,2016-02-05 15:42:00,-,-,https://nsearchives.nseindia.com/corporate/Divilab_press_05022016154203.zip,05-02-2016,1083.0,1120.0,1074.4000244140625,1110.449951171875,1038.1539306640625,474625,0.0,0.0,12-02-2016,-1
157,DIVISLAB,Divi's Laboratories Limited,financial result updates," the standalone financial results along with the limited review report for the period ended december 31, 2015.",05-Feb-2016 15:37:46,2016-02-05 15:37:46,-,-,https://nsearchives.nseindia.com/corporate/UnauditedFinancialResults31122015Nse_05022016153746.zip,05-02-2016,1083.0,1120.0,1074.4000244140625,1110.449951171875,1038.1539306640625,474625,0.0,0.0,12-02-2016,-1
158,DIVISLAB,Divi's Laboratories Limited,trading window," that the trading window for dealing in securities of the company shall remain closed for insiders of the company from january 29, 2016 to february 07, 2016 (both days inclusive) as per the code of conduct of the company under the sebi (prohibition of insider trading) regulations, 2015.",27-Jan-2016 10:12:00,2016-01-27 10:12:00,-,-,https://nsearchives.nseindia.com/corporate/DIVISLAB_27012016101220.zip,27-01-2016,1085.0,1148.800048828125,1085.0,1144.199951171875,1069.7066650390625,383545,0.0,0.0,03-02-2016,0
159,DIVISLAB,Divi's Laboratories Limited,updates, that the board of director of the company has appointed officials to determine materiality of an event or information and for the purpose of making disclosures to stock exchanges on which the company's securities are traded.,14-Dec-2015 08:30:00,2015-12-14 08:30:00,-,-,https://nsearchives.nseindia.com/corporate/LetterNSE_14122015083045_397.zip,14-12-2015,1130.0,1142.5,1119.699951171875,1128.949951171875,1055.4493408203125,268495,0.0,0.0,21-12-2015,0
160,DIVISLAB,Divi's Laboratories Limited,trading window," that the trading window for dealing in securities of the company shall remain closed for insiders of the company from october 24, 2015 to november 2, 2015 (both days inclusive)",21-Oct-2015 10:59:00,2015-10-21 10:59:00,-,-,https://nsearchives.nseindia.com/corporate/Divilab_21102015105901.zip,21-10-2015,1080.0,1094.0,1067.550048828125,1088.3499755859375,1017.49267578125,273662,0.0,0.0,29-10-2015,0
161,DIVISLAB,Divi's Laboratories Limited,allotment of securities," that allotment committee of board of directors in its meeting held on september 28, 2015 made the allotment of 13,27,34,290 equity shares of rs.2/- each as bonus shares to the shareholders of the company in the ratio of 1:1. consequently, the paid-up equity share capital of the company has increased to 26,54,68,580 equity shares from 13,27,34,290 equity shares of face value rs. 2/- each.",28-Sep-2015 10:24:00,2015-09-28 10:24:00,-,-,https://nsearchives.nseindia.com/corporate/OutcomeOfAllotmentNSE_28092015102422_191.zip,28-09-2015,1130.0,1137.0,1094.449951171875,1108.6500244140625,1036.4710693359375,546436,0.0,0.0,06-10-2015,0
162,DIVISLAB,Divi's Laboratories Limited,record date," that the company has fixed record date as september 26, 2015 for the purpose of determining the eligibility of shareholders entitled to receive the bonus shares.",14-Sep-2015 11:49:00,2015-09-14 11:49:00,-,-,https://nsearchives.nseindia.com/corporate/RecordDateIntimation_14092015114913_438.zip,14-09-2015,1077.5,1104.074951171875,1066.550048828125,1096.050048828125,1024.69140625,540042,0.0,0.0,22-09-2015,0
163,DIVISLAB,Divi's Laboratories Limited,postal ballot updates, the details of voting results of the postal ballot along with report of scrutinizer pursuant to clause 35a of the listing agreement.,14-Sep-2015 10:53:00,2015-09-14 10:53:00,-,-,https://nsearchives.nseindia.com/corporate/Clause35ANse_14092015105305_419.zip,14-09-2015,1077.5,1104.074951171875,1066.550048828125,1096.050048828125,1024.69140625,540042,0.0,0.0,22-09-2015,0
164,DIVISLAB,Divi's Laboratories Limited,disclosure of voting pattern - clause 35a," the details of voting results of the annual general meeting of the company held on august 31, 2015 along with report of scrutinizer pursuant to clause 35a of the listing agreement.",01-Sep-2015 16:23:00,2015-09-01 16:23:00,-,-,https://nsearchives.nseindia.com/corporate/Divi_35A_01092015162330.zip,01-09-2015,1194.8499755859375,1207.5,1129.5,1147.300048828125,1072.604736328125,748214,0.0,0.0,08-09-2015,-1
165,DIVISLAB,Divi's Laboratories Limited,annual general meeting updates," regarding the outcome of the annual general meeting of the company held on august 31, 2015.",31-Aug-2015 15:16:00,2015-08-31 15:16:00,-,-,https://nsearchives.nseindia.com/corporate/AGMOutcomeNSE_31082015151605_294.zip,31-08-2015,1124.5,1200.0,1114.875,1182.050048828125,1105.0924072265625,870912,0.0,0.0,07-09-2015,-1
166,DIVISLAB,Divi's Laboratories Limited,postal ballot updates," a copy of the postal ballot notice, pursuant to section 110 and other applicable provisions, if any, of the companies act, (the ""act""), 2013 read together with the companies ( management and administration) rules, 2014.",14-Aug-2015 11:08:00,2015-08-14 11:08:00,-,-,https://nsearchives.nseindia.com/corporate/DIVISLAB_pb_14082015110818.zip,14-08-2015,1091.0,1106.7249755859375,1077.5,1091.4749755859375,1020.4142456054688,418214,0.0,0.0,21-08-2015,1
167,DIVISLAB,Divi's Laboratories Limited,trading window," that the trading window for dealing in securities of the company shall remain closed for insiders of the company from august 1, 2015 to august 10, 2015 (both days inclusive) as per the code of conduct of the company under the sebi (prohibition of lnsider trading) regulations, 2015.",30-Jul-2015 10:33:00,2015-07-30 10:33:00,-,-,https://nsearchives.nseindia.com/corporate/divis_30072015103330.zip,30-07-2015,962.0,971.0,957.5,965.0750122070312,893.2066650390625,373364,0.0,0.0,06-08-2015,0
168,DIVISLAB,Divi's Laboratories Limited,agm/book closure," that the register of members and share transfer books of the company will remain closed from august 10, 2015 to august 14, 2015(both days inclusive) for the purpose of annual general meeting of the company and payment of dividend, if declared at the ensuing annual general meeting.",20-Jul-2015 14:46:00,2015-07-20 14:46:00,-,-,https://nsearchives.nseindia.com/corporate/BookClosureNSE_20072015144604_310.zip,20-07-2015,992.5,999.875,975.0,979.5750122070312,906.6268920898438,369436,0.0,0.0,27-07-2015,0
169,DIVISLAB,Divi's Laboratories Limited,trading window," that the trading window for dealing in securities of the company shall remain closed for insiders of the company from may 16, 2015 to may 25, 2015 (both days inclusive) as per the code of conduct of the company under the sebi prohibition of insider trading regulations, 1992.",12-May-2015 12:43:00,2015-05-12 12:43:00,-,-,https://nsearchives.nseindia.com/corporate/divislab_05122015124301_1.zip,12-05-2015,865.0,882.4500122070312,858.0,871.1500244140625,806.2762451171875,527612,0.0,0.0,19-05-2015,0
170,DIVISLAB,Divi's Laboratories Limited,disc. under reg.30 of sebi (sast) reg.2011,"dr. murali k. divi has submitted to the exchange vide letter dated april 03, 2015 a copy of disclosure under regulation 30(1) and 30(2) of sebi (substantial acquisition of shares & takeovers) regulations, 2011.",13-Apr-2015 10:11:00,2015-04-13 10:11:00,-,-,https://nsearchives.nseindia.com/corporate/divislaboratoriesltd_drmuralikdivi0001_04132015101102_1.zip,13-04-2015,974.9749755859376,976.5,956.2999877929688,966.3250122070312,894.363525390625,271886,0.0,0.0,21-04-2015,-1
171,DIVISLAB,Divi's Laboratories Limited,disclosure of voting pattern - clause 35a, a copy of result of postal ballot pursuant to clause 35a of the listing agreement along with report of scrutinizer.,20-Mar-2015 12:51:00,2015-03-20 12:51:00,-,-,https://nsearchives.nseindia.com/corporate/Clause35ANSE_03202015125101_1.zip,20-03-2015,913.0,927.3250122070312,895.125,903.1500244140624,835.8931884765625,323112,0.0,0.0,27-03-2015,0
172,DIVISLAB,Divi's Laboratories Limited,postal ballot updates," that in continuation to the company's earlier announcement dated 17.02.2015 with reference to the postal ballot notice, the date of declaration of postal ballot results has been inadvertently mentioned as march 21, 2015 instead of march 20, 2015.     accordingly, the date of declaration of postal ballot results should be taken as march 20, 2015.",23-Feb-2015 17:39:00,2015-02-23 17:39:00,-,-,https://nsearchives.nseindia.com/corporate/CoveringLetterNSE_02232015173902_1.zip,23-02-2015,848.0,849.4500122070312,838.4500122070312,842.5999755859375,779.852294921875,593010,0.0,0.0,02-03-2015,0
173,DIVISLAB,Divi's Laboratories Limited,trading window," that the trading window for dealing in securities of the company shall remain closed for insiders of the company from january 24, 2015 to february 2, 2015 (both days inclusive) as per the code of conduct of the company under the sebi prohibition of insider trading regulations, 1992.",21-Jan-2015 16:45:00,2015-01-21 16:45:00,-,-,https://nsearchives.nseindia.com/corporate/DIVISLAB_BM_01212015164502_2.zip,21-01-2015,852.0,852.5250244140625,836.4000244140625,839.625,777.0988159179688,225258,0.0,0.0,29-01-2015,1
174,DIVISLAB,Divi's Laboratories Limited,financial result updates, the standalone financial results along with the limited review report for the period ended 30-sep-2014.,03-Nov-2014 08:31:03,2014-11-03 08:31:03,-,-,https://nsearchives.nseindia.com/corporate/DIVISLAB_30092014_S_LR_11032014083102_.zip,03-11-2014,935.0499877929688,936.5,898.2750244140625,902.7999877929688,835.5692749023438,681916,0.0,0.0,12-11-2014,0
175,DIVISLAB,Divi's Laboratories Limited,press release," regarding a press release dated november 01, 2014 titled "" divi's labs earns a pat of rs 230 crores in q2 of fy15"".",03-Nov-2014 08:08:00,2014-11-03 08:08:00,-,-,https://nsearchives.nseindia.com/corporate/DIVIS_11032014080801_1.zip,03-11-2014,935.0499877929688,936.5,898.2750244140625,902.7999877929688,835.5692749023438,681916,0.0,0.0,12-11-2014,0
176,DIVISLAB,Divi's Laboratories Limited,annual general meeting updates," regarding outcome of annual general meeting held on august 25, 2014.",26-Aug-2014 18:08:00,2014-08-26 18:08:00,-,-,https://nsearchives.nseindia.com/corporate/divi_outcome_08262014180802_3.zip,26-08-2014,796.375,801.7000122070312,775.75,788.2999877929688,729.595947265625,236518,0.0,0.0,03-09-2014,0
177,DIVISLAB,Divi's Laboratories Limited,disclosure of voting pattern - clause 35a, details of voting results pursuant to clause 35a of the listing agreement.,26-Aug-2014 17:44:00,2014-08-26 17:44:00,-,-,https://nsearchives.nseindia.com/corporate/Clause35A_08262014174402_2.zip,26-08-2014,796.375,801.7000122070312,775.75,788.2999877929688,729.595947265625,236518,0.0,0.0,03-09-2014,0
178,DIVISLAB,Divi's Laboratories Limited,press release," regarding a press release dated august 11, 2014, titled ""divi's labs earns a pat of rs.168 crores for q1 of fy15"".",12-Aug-2014 08:56:00,2014-08-12 08:56:00,-,-,https://nsearchives.nseindia.com/corporate/DIVI_PR_08122014085603_2.zip,12-08-2014,748.5250244140625,748.5250244140625,724.0999755859375,737.0,682.1162719726562,936198,0.0,0.0,20-08-2014,0
179,DIVISLAB,Divi's Laboratories Limited,financial result updates, the standalone financial results along with the limited review report for the period ended 30-jun-2014.,11-Aug-2014 18:43:02,2014-08-11 18:43:02,-,-,https://nsearchives.nseindia.com/corporate/DIVISLAB30062014_08112014184302_.zip,11-08-2014,754.5,762.4249877929688,746.0750122070312,755.1749877929688,698.9378051757812,315814,0.0,0.0,19-08-2014,0
180,DIVISLAB,Divi's Laboratories Limited,agm/book closure," that the company has fixed book closure from august 4, 2014 to august 8, 2014 (both days inclusive) for the purpose of the annual general meeting of the company scheduled to be held on august 25, 2014 and payment of dividend, if declared at the ensuing annual general meeting. dividend, when declared at the annual general meeting, will be credited / dispatched on or before september 08, 2014. further, in compliance with section 108 of the companies act, 2013 and rule 20 of the companies (management and administration) rules 2014 and clause 35b of the listing agreement the company is providing e-voting facility to its members in respect of the businesses to be transacted at the annual general meeting. the voting rights of the members shall be in proportion to the paid-up value of their shares in the equity capital of the company as on the cut-off date, being july 25, 2014.",16-Jul-2014 18:36:00,2014-07-16 18:36:00,-,-,https://nsearchives.nseindia.com/corporate/BookclosureNSE_07162014183601_1.zip,16-07-2014,722.625,749.5,717.5250244140625,743.8499755859375,679.2247314453125,272544,0.0,0.0,23-07-2014,0
181,DIVISLAB,Divi's Laboratories Limited,disclosure under insider trading regulation," vide letter dated july 11, 2014 a copy of disclosure pursuant to regulation 13(2), 13(2a) and 13(6) of the sebi (prohibition of insider trading) regulations, 1992.",14-Jul-2014 08:20:00,2014-07-14 08:20:00,-,-,https://nsearchives.nseindia.com/corporate/FormBNSE_07142014082002_1.zip,14-07-2014,731.0,744.9749755859375,707.5750122070312,713.2999877929688,651.3287963867188,336086,0.0,0.0,21-07-2014,1
182,DIVISLAB,Divi's Laboratories Limited,updates," that the company is glad to announce that it has had a successful inspection by the us-fda from 16th to 20th june, 2014, without any observations, for its unit-1 at vill. lingojigudem, choutuppal mandal near hyderabad during this month. the purpose of this inspection was for general cgmp (current good manufacturing practices) for the facility.",20-Jun-2014 16:32:00,2014-06-20 16:32:00,-,-,https://nsearchives.nseindia.com/corporate/AnnouncementNSE_06202014163202_1.zip,20-06-2014,677.4500122070312,681.9749755859375,657.5250244140625,662.1749877929688,604.6455688476562,567812,0.0,0.0,27-06-2014,1
183,DIVISLAB,Divi's Laboratories Limited,financial result updates, the standalone & consolidated financial results for the period ended 31-mar-2014.,26-May-2014 10:23:02,2014-05-26 10:23:02,-,-,https://nsearchives.nseindia.com/corporate/DIVISLAB_31Mar2014_B_05262014102301_.zip,26-05-2014,637.5,637.5,605.0,621.3250122070312,567.3446044921875,1137278,0.0,0.0,02-06-2014,0
184,DIVISLAB,Divi's Laboratories Limited,press release," regarding a press release dated may 24, 2014, titled""divi's labs earns a consolidated total income of rs.2532 crores in fy14"".",26-May-2014 08:08:00,2014-05-26 08:08:00,-,-,https://nsearchives.nseindia.com/corporate/DIVISLAB_PR_26052014_05262014080802_3.zip,26-05-2014,637.5,637.5,605.0,621.3250122070312,567.3446044921875,1137278,0.0,0.0,02-06-2014,0
185,DIVISLAB,Divi's Laboratories Limited,disclosure of voting pattern - clause 35a, regarding results of the postal ballot  pursuant to clause 35a of the listing agreement.,05-May-2014 17:40:00,2014-05-05 17:40:00,-,-,https://nsearchives.nseindia.com/corporate/Clause35A_05052014174002_1.zip,05-05-2014,691.0,693.9249877929688,674.5,680.4500122070312,621.3328247070312,178868,0.0,0.0,12-05-2014,0
186,DIVISLAB,Divi's Laboratories Limited,disclosure under insider trading regulation," vide letter dated april 26, 2014 a copy of disclosure pursuant to regulation 13(6) of the sebi (prohibition of insider trading) regulations, 1992.",28-Apr-2014 11:20:00,2014-04-28 11:20:00,-,-,https://nsearchives.nseindia.com/corporate/FormD_04282014112002_2.zip,28-04-2014,687.4749755859375,704.2750244140625,686.3499755859375,698.7249755859375,638.0201416015625,829218,0.0,0.0,06-05-2014,0
187,DIVISLAB,Divi's Laboratories Limited,disclosure under insider trading regulation," vide letter dated april 23, 2014 a copy of disclosure pursuant to regulation 13(6) of the sebi (prohibition of insider trading) regulations, 1992.",23-Apr-2014 11:24:00,2014-04-23 11:24:00,-,-,https://nsearchives.nseindia.com/corporate/FormD_04232014112401_1.zip,23-04-2014,682.9500122070312,688.4749755859375,681.0,683.7999877929688,624.391845703125,372476,0.0,0.0,30-04-2014,0
188,DIVISLAB,Divi's Laboratories Limited,disclosure under insider trading regulation," vide letter dated april 07, 2014 a copy of disclosure pursuant to regulation 13(6) of the sebi (prohibition of insider trading) regulations, 1992.",07-Apr-2014 16:00:00,2014-04-07 16:00:00,-,-,https://nsearchives.nseindia.com/corporate/FormD_04072014160003_3.zip,07-04-2014,676.625,680.0,665.4749755859375,675.2999877929688,616.6302490234375,289768,0.0,0.0,16-04-2014,0
189,DIVISLAB,Divi's Laboratories Limited,postal ballot updates," a copy of the notice of postal ballot, pursuant to section 192a(2) of the companies act, 1956 read with the companies (passing of the resolution by postal ballot) rules, 2011.",04-Apr-2014 14:20:00,2014-04-04 14:20:00,-,-,https://nsearchives.nseindia.com/corporate/DIVILAB_PB_04042014_04042014142001_1.zip,04-04-2014,687.9500122070312,690.25,673.4749755859375,674.7999877929688,616.1737060546875,174168,0.0,0.0,15-04-2014,0
190,DIVISLAB,Divi's Laboratories Limited,disclosure under insider trading regulation," vide letter dated march 11, 2014 a copy of disclosure pursuant to regulation 13(4), 13(4a) and 13(6) of the sebi (prohibition of insider trading) regulations, 1992.",11-Mar-2014 10:20:00,2014-03-11 10:20:00,-,-,https://nsearchives.nseindia.com/corporate/FormD_03112014102001_1.zip,11-03-2014,692.4500122070312,699.3250122070312,683.0250244140625,686.9749755859375,627.291015625,349502,0.0,0.0,19-03-2014,0
191,DIVISLAB,Divi's Laboratories Limited,disclosure under insider trading regulation," vide letter dated march 04, 2014 a copy of disclosure pursuant to regulation 13(4), 13(4a) and 13(6) of the sebi (prohibition of insider trading) regulations, 1992.",04-Mar-2014 14:24:00,2014-03-04 14:24:00,-,-,https://nsearchives.nseindia.com/corporate/FormD_03042014142401_2.zip,04-03-2014,720.0499877929688,722.5,712.625,716.2249755859375,653.9996948242188,273378,0.0,0.0,11-03-2014,0
192,DIVISLAB,Divi's Laboratories Limited,disclosure under insider trading regulation," vide letter dated february 26, 2014 a copy of disclosure pursuant to regulation 13(4), 13(4a) and 13(6) of the sebi (prohibition of insider trading) regulations, 1992.",26-Feb-2014 14:48:00,2014-02-26 14:48:00,-,-,https://nsearchives.nseindia.com/corporate/FormD_02262014144801_2.zip,26-02-2014,713.0,723.5,703.2249755859375,709.7999877929688,648.1328735351562,437542,0.0,0.0,06-03-2014,0
193,DIVISLAB,Divi's Laboratories Limited,disclosure under insider trading regulation," vide letter dated february 10, 2014 a copy of disclosure pursuant to regulation 13(4), 13(4a) and 13(6) of the sebi (prohibition of insider trading) regulations, 1992.",10-Feb-2014 14:48:00,2014-02-10 14:48:00,-,-,https://nsearchives.nseindia.com/corporate/FormD_02102014144801_1.zip,10-02-2014,695.0,697.3499755859375,683.5750122070312,685.7750244140625,626.1951904296875,189462,0.0,0.0,17-02-2014,0
194,DIVISLAB,Divi's Laboratories Limited,press release," regarding press release, titled ""divi's labs earns a pat of rs.219 crores in q3 of fy14"".",04-Feb-2014 08:28:00,2014-02-04 08:28:00,-,-,https://nsearchives.nseindia.com/corporate/DIVIS_pr_04022014_02042014082801_1.zip,04-02-2014,682.5,695.0,665.75,670.75,612.4755249023438,1547316,0.0,0.0,11-02-2014,0
195,DIVISLAB,Divi's Laboratories Limited,disclosure under insider trading regulation," vide letter dated january 27, 2014 a copy of disclosure pursuant to regulation 13(4), 13(4a) and 13(6) of the sebi (prohibition of insider trading) regulations, 1992.",27-Jan-2014 12:56:00,2014-01-27 12:56:00,-,-,https://nsearchives.nseindia.com/corporate/FormD-NSE_01272014125601_1.zip,27-01-2014,663.4749755859375,663.4749755859375,650.6749877929688,654.3499755859375,597.5003051757812,325360,0.0,0.0,03-02-2014,0
196,DIVISLAB,Divi's Laboratories Limited,disclosure under insider trading regulation," vide letter dated january 04, 2014 a copy of disclosure pursuant to regulation 13(4), 13(4a) and 13(6) of the sebi (prohibition of insider trading) regulations, 1992.",06-Jan-2014 10:04:00,2014-01-06 10:04:00,-,-,https://nsearchives.nseindia.com/corporate/FormD-NSE_01062014100402_4.zip,06-01-2014,628.4000244140625,630.0,618.5,626.9500122070312,572.4810180664062,327226,0.0,0.0,13-01-2014,0
197,DIVISLAB,Divi's Laboratories Limited,disclosure of voting pattern - clause 35a," regarding the details of voting results at the annual general meeting of the company held on august 05, 2013, under clause 35a.",06-Aug-2013 10:32:00,2013-08-06 10:32:00,-,-,https://nsearchives.nseindia.com/corporate/DIVILAB_disc35A_06082013_08062013103202_1.zip,06-08-2013,472.5,478.9500122070313,463.2250061035156,466.2250061035156,425.7196960449219,325230,0.0,0.0,14-08-2013,1
198,DIVISLAB,Divi's Laboratories Limited,disclosure of voting pattern - clause 35a," regarding details of voting results of annual general meeting of the company held on august 05, 2013 pursuant to clause 35a of listing agreement.",05-Aug-2013 17:52:00,2013-08-05 17:52:00,-,-,https://nsearchives.nseindia.com/corporate/Votingresults35A_08052013175202_1.zip,05-08-2013,467.5,479.5,455.0,477.3500061035156,435.8781127929688,724764,0.0,0.0,13-08-2013,0
199,DIVISLAB,Divi's Laboratories Limited,annual general meeting updates," regarding a outcome of annual general meeting of the company held on august 05, 2013.",05-Aug-2013 14:16:00,2013-08-05 14:16:00,-,-,https://nsearchives.nseindia.com/corporate/DIVISLAB_OUTCOMEAGM_05082013_08052013141602_2.zip,05-08-2013,467.5,479.5,455.0,477.3500061035156,435.8781127929688,724764,0.0,0.0,13-08-2013,0
200,DIVISLAB,Divi's Laboratories Limited,press release," vide letter dated august 03, 2013 regarding a press release, titled ""divi's labs earns a pat of rs.175 crores for q1 of fy14"".",05-Aug-2013 12:44:00,2013-08-05 12:44:00,-,-,https://nsearchives.nseindia.com/corporate/DIVISLAB_Pr_05082013_08052013124401_2.zip,05-08-2013,467.5,479.5,455.0,477.3500061035156,435.8781127929688,724764,0.0,0.0,13-08-2013,0
201,DIVISLAB,Divi's Laboratories Limited,financial result updates," the standalone financial results along with the limited review report for the period ended june 30,2013.",05-Aug-2013 10:05:55,2013-08-05 10:05:55,-,-,https://nsearchives.nseindia.com/corporate/DIVISLAB_30JUN2013_S_Q1.zip,05-08-2013,467.5,479.5,455.0,477.3500061035156,435.8781127929688,724764,0.0,0.0,13-08-2013,0
202,DIVISLAB,Divi's Laboratories Limited,discl. under sebi insider trading and takeover regulation," vide letter dated july 16, 2013 a copy of disclosure pursuant to regulation 13(3) and 13(6) of the sebi (prohibition of insider trading) regulations, 1992",16-Jul-2013 16:44:00,2013-07-16 16:44:00,-,-,https://nsearchives.nseindia.com/corporate/DisclosureFormC_07162013164402_1.zip,16-07-2013,502.5,503.6000061035156,495.1000061035156,498.125,447.807861328125,146682,0.0,0.0,23-07-2013,0
203,DIVISLAB,Divi's Laboratories Limited,discl. under sebi insider trading and takeover regulation,"reliance capital asset management limited has submitted to the exchange vide letter dated july 15, 2013 a copy of disclosure under regulation 29(2) of sebi (substantial acquisition of shares & takeovers) regulations, 2011 along with a copy of disclosure pursuant to regulation 13(3) and 13(6) of the sebi (prohibition of insider trading) regulations, 1992",16-Jul-2013 13:16:00,2013-07-16 13:16:00,-,-,https://nsearchives.nseindia.com/corporate/Divislaboratories_07162013131601_1.zip,16-07-2013,502.5,503.6000061035156,495.1000061035156,498.125,447.807861328125,146682,0.0,0.0,23-07-2013,0
204,DIVISLAB,Divi's Laboratories Limited,agm/book closure," that the share transfer books of the company will remain close from july 29, 2013 to august 2, 2013(both days inclusive) for the purpose of the annual general meeting of the company scheduled to be held on august 05, 2013 and payment of dividend, if declared at the ensuing annual general meeting. ",01-Jul-2013 14:40:00,2013-07-01 14:40:00,-,-,https://nsearchives.nseindia.com/corporate/AGMNotice_07012013144001_1.zip,01-07-2013,497.0,499.9750061035156,487.5,494.75,444.7737731933594,493776,0.0,0.0,08-07-2013,0
205,DIVISLAB,Divi's Laboratories Limited,financial result updates," the standalone and consolidated financial results for the period ended march 31,2013.",21-May-2013 09:41:55,2013-05-21 09:41:55,-,-,https://nsearchives.nseindia.com/corporate/DIVISLAB_31MAR2013_B_Q4A.zip,21-05-2013,531.0,531.0,498.5,503.2250061035156,452.3927612304688,1609216,0.0,0.0,28-05-2013,0
206,DIVISLAB,Divi's Laboratories Limited,press release," regarding a press release dated may 20, 2013, titled ""divi's labs earns a consolidated total income of rs.2145 crores in fy13"".",21-May-2013 09:40:00,2013-05-21 09:40:00,-,-,https://nsearchives.nseindia.com/corporate/DIVILAB_pr_21052013_05212013094001_1.zip,21-05-2013,531.0,531.0,498.5,503.2250061035156,452.3927612304688,1609216,0.0,0.0,28-05-2013,0
207,DIVISLAB,Divi's Laboratories Limited,press release," regarding a press release dated february 02, 2012, titled ""divi's labs earns an income of rs.534 crores in q3 of fy13"".",04-Feb-2013 12:28:00,2013-02-04 12:28:00,-,-,https://nsearchives.nseindia.com/corporate/DIVISLAB_pr_04012013_02042013122801_1.zip,04-02-2013,535.9500122070312,539.6749877929688,515.0,522.125,469.3835754394531,429330,0.0,0.0,11-02-2013,0
208,DIVISLAB,Divi's Laboratories Limited,financial result updates," the standalone financial results for the period ended december 31,2012 with limited review report.",04-Feb-2013 09:23:47,2013-02-04 09:23:47,-,-,https://nsearchives.nseindia.com/corporate/DIVISLAB_31DEC2012_S_Q3.zip,04-02-2013,535.9500122070312,539.6749877929688,515.0,522.125,469.3835754394531,429330,0.0,0.0,11-02-2013,0
209,DIVISLAB,Divi's Laboratories Limited,press release," regarding a press release dated november 03, 2012, titled ""divi's labs earns an income of rs.474 crores in q2 of fy13"".",05-Nov-2012 08:44:00,2012-11-05 08:44:00,-,-,https://nsearchives.nseindia.com/corporate/DIVIO_PR_05112012.ZIP,05-11-2012,592.0,596.5250244140625,552.0,573.4000244140625,515.4791870117188,937042,0.0,0.0,12-11-2012,0
210,DIVISLAB,Divi's Laboratories Limited,news clarification," vide letter dated august 28, 2012, regarding ""clarification on rumours about financial irregularity"".",28-Aug-2012 13:29:00,2012-08-28 13:29:00,-,-,https://nsearchives.nseindia.com/corporate/DivisLab_clarif_28082012.zip,28-08-2012,599.5,599.5,547.4749755859375,565.4000244140625,508.2872924804688,2386924,0.0,0.0,04-09-2012,0
211,DIVISLAB,Divi's Laboratories Limited,disclosure of voting pattern - clause 35a," regarding details of voting results of annual general meeting of the company held on august 06, 2012 pursuant to clause 35a of listing agreement.",06-Aug-2012 18:25:00,2012-08-06 18:25:00,-,-,https://nsearchives.nseindia.com/corporate/DIVIS_35A_06082012.zip,06-08-2012,565.7999877929688,570.0,556.4500122070312,562.125,505.3431091308594,605770,0.0,0.0,13-08-2012,0
212,DIVISLAB,Divi's Laboratories Limited,outcome of annual general meeting," regarding the outcome of the annual general meeting of the company held on august 06, 2012.",06-Aug-2012 13:16:00,2012-08-06 13:16:00,-,-,https://nsearchives.nseindia.com/corporate/DIVI_OAGM_06082012.zip,06-08-2012,565.7999877929688,570.0,556.4500122070312,562.125,505.3431091308594,605770,0.0,0.0,13-08-2012,0
213,DIVISLAB,Divi's Laboratories Limited,press release," regarding the press release dated august 04, 2012 titled ""divi's labs earns a pbt of rs.214 crores for q1 of fy13"".",06-Aug-2012 10:19:00,2012-08-06 10:19:00,-,-,https://nsearchives.nseindia.com/corporate/DIVIS_pr_06082012.zip,06-08-2012,565.7999877929688,570.0,556.4500122070312,562.125,505.3431091308594,605770,0.0,0.0,13-08-2012,0
214,DIVISLAB,Divi's Laboratories Limited,financial result updates," the standalone financial results along with the limited review report for the period ended june 30, 2012.",06-Aug-2012 10:14:53,2012-08-06 10:14:53,-,-,https://nsearchives.nseindia.com/corporate/DIVISLAB_30JUN2012_S_Q1.zip,06-08-2012,565.7999877929688,570.0,556.4500122070312,562.125,505.3431091308594,605770,0.0,0.0,13-08-2012,0
215,DIVISLAB,Divi's Laboratories Limited,clarification," vide letter dated july 13, 2012, regarding ""clarification on order/closure notice of ap pollution control board"".",13-Jul-2012 10:35:00,2012-07-13 10:35:00,-,-,https://nsearchives.nseindia.com/corporate/DiviLab_clarification_13072012.zip,13-07-2012,515.0,525.375,505.8500061035156,523.125,464.729248046875,249432,0.0,0.0,20-07-2012,0
216,DIVISLAB,Divi's Laboratories Limited,disclosure of voting pattern - clause 35a,", vide letter dated april 20, 2012 regarding ""clause 35a - declaration of postal ballot results"".",20-Apr-2012 19:56:00,2012-04-20 19:56:00,-,-,https://nsearchives.nseindia.com/corporate/divis_rpb_20042012.zip,20-04-2012,425.3500061035156,426.2250061035156,410.0499877929688,416.625,370.11767578125,332988,0.0,0.0,27-04-2012,0
217,DIVISLAB,Divi's Laboratories Limited,notice of postal ballot," a copy of notice pursuant to section 192a of the companies act, 1956 read with the companies (passing of the resolution by postal ballot) rules, 2011 in respect of the resolution to be passed through postal ballot : (1) re-appointment and revision in remuneration of mr. madhusudana rao divi as director - projects of the company, (2) re-appointment and revision in remuneration of mr. kiran s. divi as director & president- operations of the company, (3) enhancement of remuneration of dr. murali k. divi, chairman & managing director of the company, (4)enhancement of remuneration of mr. n. v. ramana, executive director of the company.",19-Mar-2012 18:20:00,2012-03-19 18:20:00,-,-,https://nsearchives.nseindia.com/corporate/Divis_NPB_190312.zip,19-03-2012,374.9750061035156,374.9750061035156,360.0249938964844,360.4500122070313,320.21343994140625,92302,0.0,0.0,26-03-2012,0
218,DIVISLAB,Divi's Laboratories Limited,press release,"divi's laboratories limited  has informed the exchange regarding a press release dated january 28, 2012, titled ""divi's labs earns an income of rs.417 crores in q3 of fy11-12"".",30-Jan-2012 08:07:00,2012-01-30 08:07:00,-,-,https://nsearchives.nseindia.com/corporate/Divis_pr_30012012.zip,30-01-2012,408.7999877929688,408.7999877929688,382.5,392.7999877929688,348.95220947265625,792224,0.0,0.0,06-02-2012,0
219,DIVISLAB,Divi's Laboratories Limited,press release," regarding a press release dated november 01, 2011, titled ""divi's labs earns an income of rs.366 crores in q2 of fy11"".",01-Nov-2011 18:25:00,2011-11-01 18:25:00,-,-,https://nsearchives.nseindia.com/corporate/DiviLab_pr_01112011.zip,01-11-2011,385.75,387.9500122070313,378.6499938964844,380.2999877929688,337.8475646972656,226482,0.0,0.0,09-11-2011,0
220,DIVISLAB,Divi's Laboratories Limited,"reg.3(3) of sebi (substantial acq of shares &takeovers),1997","kiran s divi has submitted to the exchange a copy of disclosure under regulation 3(3) of the sebi (substantial acquisition of shares and takeovers) regulations, 1997.",28-Sep-2011 18:15:00,2011-09-28 18:15:00,-,-,https://nsearchives.nseindia.com/corporate/Divilab_Kiran_28092011.zip,28-09-2011,361.5249938964844,369.5,360.1499938964844,366.2749938964844,325.3882141113281,291080,0.0,0.0,05-10-2011,0
221,DIVISLAB,Divi's Laboratories Limited,"reg.3(3) of sebi (substantial acq of shares &takeovers),1997","nilima motparti has submitted to the exchange a copy of disclosure under regulation 3(3) of the sebi (substantial acquisition of shares and takeovers) regulations, 1997.",28-Sep-2011 18:14:00,2011-09-28 18:14:00,-,-,https://nsearchives.nseindia.com/corporate/Divilabs_Nilima_28092011.zip,28-09-2011,361.5249938964844,369.5,360.1499938964844,366.2749938964844,325.3882141113281,291080,0.0,0.0,05-10-2011,0
222,DIVISLAB,Divi's Laboratories Limited,outcome of annual general meeting," regarding the outcome of the annual general meeting of the members of the company held on august 08, 2011.",08-Aug-2011 13:16:00,2011-08-08 13:16:00,-,-,https://nsearchives.nseindia.com/corporate/DIVIS_outcomeofagm_08082011.zip,08-08-2011,375.0499877929688,394.5,375.0499877929688,390.8250122070313,347.1976928710937,396746,0.0,0.0,16-08-2011,-1
223,DIVISLAB,Divi's Laboratories Limited,financial result updates," the standalone and consolidated financial results for the period ended march 31,2011.",23-May-2011 09:50:30,2011-05-23 09:50:30,-,-,https://nsearchives.nseindia.com/corporate/DIVISLAB_31MAR2011_B_Q4A.zip,23-05-2011,369.5,376.3250122070313,364.9750061035156,372.125,326.3715209960937,3930402,0.0,0.0,30-05-2011,0
224,DIVISLAB,Divi's Laboratories Limited,press release," regarding a press release dated may 20, 2011, titled ""divi's labs pat for q4 grew by 36% to rs.175 crores"".",23-May-2011 08:56:00,2011-05-23 08:56:00,-,-,https://nsearchives.nseindia.com/corporate/DIVI_PR_23052011.zip,23-05-2011,369.5,376.3250122070313,364.9750061035156,372.125,326.3715209960937,3930402,0.0,0.0,30-05-2011,0
225,DIVISLAB,Divi's Laboratories Limited,press release," regarding a press release dated february 04, 2011, titled ""divi's labs earns an income of rs.313 crores for q3 of fy11"".",04-Feb-2011 11:52:00,2011-02-04 11:52:00,-,-,https://nsearchives.nseindia.com/corporate/DIVISLAB_pr_04022011.zip,04-02-2011,318.45001220703125,332.5,316.3500061035156,328.4750061035156,288.0883483886719,875302,0.0,0.0,11-02-2011,0
226,DIVISLAB,Divi's Laboratories Limited,financial result updates," the standalone and consolidated financial results for the period ended december 31,2010.",04-Feb-2011 11:50:26,2011-02-04 11:50:26,-,-,https://nsearchives.nseindia.com/corporate/DIVISLAB_31DEC2010_B_Q3.zip,04-02-2011,318.45001220703125,332.5,316.3500061035156,328.4750061035156,288.0883483886719,875302,0.0,0.0,11-02-2011,0
227,DIVISLAB,Divi's Laboratories Limited,press release," regarding a press release dated november 09, 2010 , titled ""divi's labs earns an income of rs. 524 crores in h1 of fy10""",09-Nov-2010 19:17:00,2010-11-09 19:17:00,-,-,https://nsearchives.nseindia.com/corporate/DIVI_PR_09112010.zip,09-11-2010,371.0,378.5,368.0,370.5499877929688,324.9901123046875,956198,0.0,0.0,16-11-2010,-1
228,DIVISLAB,Divi's Laboratories Limited,financial result updates," the standalone and consolidated financial results for the period ended september 30,2010.",09-Nov-2010 18:20:32,2010-11-09 18:20:32,-,-,https://nsearchives.nseindia.com/corporate/DIVISLAB_30SEP2010_B_Q2H.zip,09-11-2010,371.0,378.5,368.0,370.5499877929688,324.9901123046875,956198,0.0,0.0,16-11-2010,-1
229,DIVISLAB,Divi's Laboratories Limited,outcome of annual general meeting," regarding the outcome of the annual general meeting of the company held on august 13, 2010.",13-Aug-2010 13:48:00,2010-08-13 13:48:00,-,-,https://nsearchives.nseindia.com/corporate/DivisLab_OAM_13082010.zip,13-08-2010,374.5,382.0,369.8250122070313,373.7999877929688,327.8405456542969,282032,0.0,0.0,20-08-2010,0
230,DIVISLAB,Divi's Laboratories Limited,press release," regarding the press release dated august 12, 2010 titled""divi's labs earns an income of rs.265 crores in q1"".",12-Aug-2010 18:32:00,2010-08-12 18:32:00,-,-,https://nsearchives.nseindia.com/corporate/DIVIS_PR_12082010.ZIP,12-08-2010,376.4500122070313,381.25,371.1000061035156,375.3250122070313,329.1780700683594,366086,0.0,0.0,19-08-2010,0
231,DIVISLAB,Divi's Laboratories Limited,press release," regarding a press release dated  may 22, 2010 , titled "" divi's labs earns a pat of rs. 129 crores for q4"".",24-May-2010 09:01:00,2010-05-24 09:01:00,-,-,https://nsearchives.nseindia.com/corporate/Divis_PR1_24052010.zip,24-05-2010,350.0,365.0,350.0,359.7250061035156,313.07305908203125,959380,0.0,0.0,31-05-2010,0
